Document_and_Entity_Informatio
Document and Entity Information (USD $) | 12 Months Ended | ||
Dec. 31, 2013 | Feb. 28, 2014 | Jun. 30, 2013 | |
Document and Entity Information [Abstract] | ' | ' | ' |
Entity Registrant Name | 'HOOPER HOLMES INC | ' | ' |
Entity Central Index Key | '0000741815 | ' | ' |
Current Fiscal Year End Date | '--12-31 | ' | ' |
Entity Filer Category | 'Smaller Reporting Company | ' | ' |
Document Type | '10-K | ' | ' |
Document Period End Date | 31-Dec-13 | ' | ' |
Document Fiscal Year Focus | '2013 | ' | ' |
Document Fiscal Period Focus | 'FY | ' | ' |
Amendment Flag | 'false | ' | ' |
Entity Public Float | ' | ' | $23,000,000 |
Entity Common Stock, Shares Outstanding | ' | 70,420,044 | ' |
Entity Current Reporting Status | 'Yes | ' | ' |
Entity Voluntary Filers | 'No | ' | ' |
Entity Well-known Seasoned Issuer | 'No | ' | ' |
Consolidated_Balance_Sheets
Consolidated Balance Sheets (USD $) | Dec. 31, 2013 | Dec. 31, 2012 |
In Thousands, unless otherwise specified | ||
ASSETS | ' | ' |
Cash and cash equivalents | $3,970 | $8,319 |
Accounts receivable, net of allowance for doubtful accounts of $153 and $662 at December 31, 2013 and 2012, respectively | 8,398 | 17,018 |
Inventories | 1,376 | 1,290 |
Other current assets | 1,597 | 374 |
Assets held for sale | 714 | 3,646 |
Total current assets | 16,055 | 30,647 |
Property, plant and equipment, net | 3,761 | 5,634 |
Other assets | 1,830 | 137 |
Total assets | 21,646 | 36,418 |
LIABILITIES AND STOCKHOLDERS' EQUITY | ' | ' |
Accounts payable | 3,440 | 6,783 |
Accrued expenses | 4,036 | 4,439 |
Liabilities held for sale | 0 | 220 |
Total current liabilities | 7,476 | 11,442 |
Other long-term liabilities | 870 | 1,115 |
Commitments and contingencies (Note 10) | ' | ' |
Stockholders’ Equity: | ' | ' |
Common stock, par value $.04 per share; Authorized 240,000,000 shares; Issued: 70,382,544 shares and 69,844,782 shares at December 31, 2013 and 2012, respectively. Outstanding: 70,373,149 shares and 69,835,387 shares at December 31, 2013 and 2012, respectively | 2,815 | 2,794 |
Additional paid-in capital | 150,235 | 149,542 |
Accumulated deficit | -139,679 | -128,404 |
Stockholders' equity before treasury stock | 13,371 | 23,932 |
Less: Treasury stock, at cost; 9,395 shares as of December 31, 2013 and 2012 | -71 | -71 |
Total stockholders' equity | 13,300 | 23,861 |
Total liabilities and stockholders' equity | $21,646 | $36,418 |
Consolidated_Balance_Sheets_Pa
Consolidated Balance Sheets (Parentheticals) (USD $) | Dec. 31, 2013 | Dec. 31, 2012 |
In Thousands, except Share data, unless otherwise specified | ||
Statement of Financial Position [Abstract] | ' | ' |
Allowance for doubtful accounts | $153 | $662 |
Common stock, par value | $0.04 | $0.04 |
Common stock, shares authorized | 240,000,000 | 240,000,000 |
Common stock, shares issued | 70,382,444 | 69,844,782 |
Common stock, shares outstanding | 70,373,149 | 69,835,387 |
Treasury stock, number of shares | 9,395 | 9,395 |
Consolidated_Statements_of_Ope
Consolidated Statements of Operations (USD $) | 12 Months Ended | ||
In Thousands, except Share data, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
Income Statement [Abstract] | ' | ' | ' |
Revenues | $49,160 | $50,977 | $51,082 |
Cost of operations | 37,618 | 37,678 | 37,526 |
Gross profit | 11,542 | 13,299 | 13,556 |
Selling, general and administrative expenses | 20,273 | 19,543 | 21,293 |
Impairment | 212 | 227 | 0 |
Restructuring charges | 813 | 566 | 34 |
Operating loss from continuing operations | -9,756 | -7,037 | -7,771 |
Other (expense) income: | ' | ' | ' |
Interest expense | -86 | -10 | -18 |
Interest income | 5 | 26 | 62 |
Other (expense) income, net | -399 | -33 | -39 |
Other (expense) income | -480 | -17 | 5 |
Loss from continuing operations before income taxes | -10,236 | -7,054 | -7,766 |
Income tax expense | 19 | 23 | 36 |
Loss from continuing operations | -10,255 | -7,077 | -7,802 |
Discontinued operations: | ' | ' | ' |
(Loss) income from discontinued operations, net of tax | -4,450 | -10,586 | 4,216 |
Gain on sale of Portamedic and subsidiary | 3,430 | 65 | 62 |
Net loss | ($11,275) | ($17,598) | ($3,524) |
Basic and diluted (loss) earnings per share: | ' | ' | ' |
Continuing operations, basic (usd per share) | ($0.15) | ($0.10) | ($0.11) |
Continuing operations, diluted (usd per share) | ($0.15) | ($0.10) | ($0.11) |
Discontinued operations, basic (usd per share) | ($0.01) | ($0.15) | $0.06 |
Discontinued operations, diluted (usd per share) | ($0.01) | ($0.15) | $0.06 |
Net loss, basic (usd per share) | ($0.16) | ($0.25) | ($0.05) |
Net loss, diluted (usd per share) | ($0.16) | ($0.25) | ($0.05) |
Weighted average number of shares - Basic | 69,965,814 | 69,743,897 | 69,628,135 |
Weighted average number of shares - Diluted | 69,965,814 | 69,743,897 | 69,628,135 |
Consolidated_Statements_of_Sha
Consolidated Statements of Shareholders' Equity (USD $) | Total | Common Stock [Member] | Additional Paid-in Capital [Member] | Accumulated Deficit [Member] | Treasury Stock [Member] |
In Thousands, except Share data, unless otherwise specified | |||||
Balance, Value at Dec. 31, 2010 | $43,626 | $2,784 | $148,195 | ($107,282) | ($71) |
Balance, Shares at Dec. 31, 2010 | ' | 69,598,982 | ' | ' | -9,395 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ' | ' | ' | ' | ' |
Net loss | -3,524 | ' | ' | -3,524 | ' |
Exercise of share-based awards, shares | 0 | ' | ' | ' | ' |
Share-based compensation, value | 647 | 3 | 644 | ' | ' |
Share-based compensation, shares | ' | 80,000 | ' | ' | ' |
Balance, Value at Dec. 31, 2011 | 40,749 | 2,787 | 148,839 | -110,806 | -71 |
Balance, Shares at Dec. 31, 2011 | ' | 69,678,982 | ' | ' | -9,395 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ' | ' | ' | ' | ' |
Net loss | -17,598 | ' | ' | -17,598 | ' |
Exercise of share-based awards, shares | 0 | ' | ' | ' | ' |
Share-based compensation, value | 710 | 7 | 703 | ' | ' |
Share-based compensation, shares | ' | 165,800 | ' | ' | ' |
Balance, Value at Dec. 31, 2012 | 23,861 | 2,794 | 149,542 | -128,404 | -71 |
Balance, Shares at Dec. 31, 2012 | ' | 69,844,782 | ' | ' | -9,395 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ' | ' | ' | ' | ' |
Net loss | -11,275 | ' | ' | -11,275 | ' |
Exercise of share-based awards, value | 71 | 7 | 64 | ' | ' |
Exercise of share-based awards, shares | 182,930 | 182,930 | ' | ' | ' |
Share-based compensation, value | 643 | 14 | 629 | ' | ' |
Share-based compensation, shares | ' | 354,832 | ' | ' | ' |
Balance, Value at Dec. 31, 2013 | $13,300 | $2,815 | $150,235 | ($139,679) | ($71) |
Balance, Shares at Dec. 31, 2013 | ' | 70,382,544 | ' | ' | -9,395 |
Consolidated_Statements_of_Cas
Consolidated Statements of Cash Flows (USD $) | 12 Months Ended | ||
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
Cash flows from operating activities: | ' | ' | ' |
Net loss | ($11,275) | ($17,598) | ($3,524) |
Adjustments to reconcile net loss to net cash (used in) provided by operating activities: | ' | ' | ' |
Gain on sale of Portamedic and subsidiary | -3,430 | -65 | 62 |
Depreciation and amortization | 2,200 | 4,191 | 3,674 |
Amortization of deferred financing fees | 298 | 136 | 138 |
Provision for bad debt expense | -380 | 207 | 107 |
Share-based compensation expense | 643 | 710 | 647 |
Impairment of long-lived assets and gain/loss on disposal of fixed assets | 416 | 5,310 | 240 |
Change in assets and liabilities: | ' | ' | ' |
Accounts receivable | 9,000 | 1,161 | 991 |
Inventories | -62 | -5 | -73 |
Other assets | -184 | 1,334 | -438 |
Accounts payable, accrued expenses and other long-term liabilities | -4,255 | 442 | -1,038 |
Net cash (used in) provided by operating activities | -7,029 | -4,177 | 786 |
Cash flows from investing activities: | ' | ' | ' |
Cost paid to sell Portamedic | -781 | 0 | 0 |
Capital expenditures | -1,550 | -4,103 | -4,821 |
Proceeds from the sale of Portamedic | 6,053 | 0 | 0 |
Proceeds from sale of fixed assets | 0 | 51 | 0 |
Net cash provided by (used in) investing activities | 3,722 | -4,052 | -4,821 |
Cash flows from financing activities: | ' | ' | ' |
Issuance of debt | 50,827 | 0 | 0 |
Principal payments on debt | -50,827 | 0 | 0 |
Debt financing fees | -999 | -101 | -101 |
Proceeds related to the exercise of stock options | 71 | 0 | 0 |
Reduction in capital lease obligation | -114 | -268 | -338 |
Net cash used in financing activities | -1,042 | -369 | -439 |
Net decrease in cash and cash equivalents | -4,349 | -8,598 | -4,474 |
Cash and cash equivalents at beginning of year | 8,319 | 16,917 | 21,391 |
Cash and cash equivalents at end of year | 3,970 | 8,319 | 16,917 |
Supplemental disclosure of non-cash investing activities: | ' | ' | ' |
Fixed assets vouchered but not paid | 153 | 154 | 308 |
Fixed assets acquired by capital leases | 0 | 64 | 354 |
Proceeds from sale of Portamedic not received, net of costs not paid | 1,525 | 0 | 0 |
Supplemental disclosure of cash flow information: | ' | ' | ' |
Cash paid during the period for income taxes | $62 | $50 | $121 |
Summary_of_Significant_Account
Summary of Significant Accounting Policies | 12 Months Ended | |||||||||||||
Dec. 31, 2013 | ||||||||||||||
Accounting Policies [Abstract] | ' | |||||||||||||
Summary of Significant Accounting Policies | ' | |||||||||||||
Summary of Significant Accounting Policies | ||||||||||||||
(a) | Description of the Business | |||||||||||||
Hooper Holmes, Inc. and its subsidiaries (“Hooper Holmes” or the "Company”) mobilize a national network of health professionals to provide on-site health screenings, laboratory testing, risk assessment and sample collection services to wellness and disease management companies, insurance companies, employers, government organizations and academic institutions. The Company also conducts laboratory testing, assembles collection kits, conducts telephone interviews of life insurance applicants, compiles health histories, collects medical records and provides underwriting services to help life insurance companies evaluate underwriting risks. | ||||||||||||||
On September 30, 2013, the Company completed the sale of certain assets comprising its Portamedic service line. The Portamedic service line is accounted for as a discontinued operation in this Report. Accordingly, the assets and liabilities of Portamedic that were sold have been reclassified and are reported as assets and liabilities held for sale on the December 31, 2012 consolidated balance sheet. The operating results of Portamedic are segregated and reported as discontinued operations in the accompanying consolidated statements of operations for all periods presented. For further discussion on Discontinued Operations, refer to Notes 2 and 5. | ||||||||||||||
Following the sale of the Portamedic service line, the Company reassessed its segment reporting. Beginning in the fourth quarter of 2013, the Company has reported its financial results in three segments: Health and Wellness, Heritage Labs and Hooper Holmes Services. Previously reported financial statement amounts have been reclassified to reflect the new segment determination for all periods presented in this Report. For further discussion on Segments, refer to Note 15. | ||||||||||||||
(b) | Principles of Consolidation | |||||||||||||
The consolidated financial statements include the accounts of Hooper Holmes, Inc. and its wholly owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation. | ||||||||||||||
(c) | Cash and Cash Equivalents | |||||||||||||
The Company considers highly liquid investments with original maturities at the date of purchase of less than 90 days to be cash equivalents. | ||||||||||||||
(d) | Accounts Receivable | |||||||||||||
Trade accounts receivable are recorded at the invoiced amount and do not bear interest. The Company maintains allowances for doubtful accounts for (i) estimated losses resulting from the inability of our customers to make required payments and (ii) estimated amounts that customers may deduct from their remittances to the Company for billed items not in compliance with customer specifications. Allowances for uncollectible accounts are estimated based on the Company's periodic review of accounts receivable historical losses, current receivables aging and existing industry and economic data. Account balances are charged off to the allowance after all means of collections have been exhausted and potential for recovery is considered remote. Customer billing adjustments are recorded against revenue whereas adjustments for bad debts are recorded within selling, general and administrative expenses. Accounts receivable are net of an allowance for doubtful accounts and pricing adjustments totaling $0.2 million and $0.7 million as of December 31, 2013 and 2012, respectively. The Company does not have any off-balance sheet credit exposure related to its customers. | ||||||||||||||
(e) | Inventories | |||||||||||||
Inventories, which consist of finished goods and component inventory, are stated at the lower of average cost or market. Included in inventories at December 31, 2013 and 2012 are $0.4 million and $0.4 million, respectively, of finished goods and $1.0 million and $0.9 million, respectively, of components. | ||||||||||||||
(f) | Property, Plant and Equipment | |||||||||||||
Property, plant and equipment are stated at cost less accumulated depreciation. Depreciation is computed using the straight-line method over the assets’ estimated useful lives. Leasehold improvements are amortized over the shorter of the estimated useful life of the improvement or the remaining lease term. The cost of maintenance and repairs is charged to operations as incurred. | ||||||||||||||
Internal use software and website development costs are capitalized and included in property, plant and equipment in the consolidated balance sheet. These assets are depreciated over the estimated useful life of the asset using the straight-line method. Subsequent modifications or upgrades to internal use software are capitalized only to the extent that additional functionality is provided. | ||||||||||||||
(g) | Long-Lived Assets | |||||||||||||
Long-lived assets, including intangible assets with determinable useful lives, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of the assets to the future undiscounted net cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets and is charged to earnings. Assets to be disposed of are reported at the lower of the carrying amount or fair value less the costs to sell. Intangible assets with determinable useful lives are amortized on a straight line basis over their respective estimated useful lives and were fully amortized as of December 31, 2012. Amortization expense from continuing operations of $0.2 million and $0.2 million was recorded for the years ended December 31, 2012 and 2011, respectively. | ||||||||||||||
(h) | Deferred Rent | |||||||||||||
The Company accounts for scheduled rent increases contained in its leases on a straight-line basis over the term of the lease. | ||||||||||||||
(i) | Advertising | |||||||||||||
Costs related to space in publications are expensed as incurred. Advertising expense included in continuing operations was approximately $0.1 million, $0.2 million and $0.2 million in 2013, 2012 and 2011, respectively. | ||||||||||||||
(j) | Revenue Recognition | |||||||||||||
Revenue is recognized for Health and Wellness services when the wellness screening is completed and the results are delivered to customers. Revenues generated from medical record collection, laboratory testing, fingerstick test kits and other services are recognized when the related service is completed and the results are delivered to our customers. Revenue for kit assembly in Heritage Labs is recorded upon shipment to the customers. In all cases, there must be evidence of an agreement with the customer, the sales price must be fixed or determinable, delivery of services must occur and the ability to collect must be reasonably assured. | ||||||||||||||
Sales tax collected from customers and remitted to governmental authorities is accounted for on a net basis and therefore is excluded from revenues in the consolidated statements of operations. | ||||||||||||||
(k) | Share-Based Compensation | |||||||||||||
The Company recognizes share-based compensation cost on a straight-line basis over the vesting period. Compensation cost is measured at the grant date based on the fair value of the award. | ||||||||||||||
(l) | Income Taxes | |||||||||||||
Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. A valuation allowance is provided when it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income and the reversal of deferred tax liabilities during the period in which related temporary differences become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income and tax planning strategies in making this assessment. | ||||||||||||||
The Company recognizes the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the financial statements from such a position are measured based on the largest benefit that has a greater than fifty percent likelihood of being realized upon settlement with the tax authorities. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs. The Company records interest related to unrecognized tax benefits in interest expense and penalties in income tax expense. | ||||||||||||||
(m) | (Loss) Earnings per Common Share | |||||||||||||
Basic (loss) earnings per share equals net (loss) income divided by the weighted average common shares outstanding during the period. Diluted (loss) earnings per share equals net (loss) income divided by the sum of the weighted average common shares outstanding during the period plus dilutive common stock equivalents. The computation of basic and diluted (loss) earnings per share for the three years ended December 31, 2013 is included in the table below. The calculation of (loss) earnings per common share on a basic and diluted basis was the same as there was no impact of dilutive common stock equivalents for all periods presented. | ||||||||||||||
For the Years Ended December 31, | ||||||||||||||
2013 | 2012 | 2011 | ||||||||||||
(Loss) earnings - basic and diluted: | ||||||||||||||
Loss from continuing operations | $ | (10,255 | ) | $ | (7,077 | ) | $ | (7,802 | ) | |||||
(Loss) income from discontinued operations | (1,020 | ) | (10,521 | ) | 4,278 | |||||||||
Net loss | $ | (11,275 | ) | $ | (17,598 | ) | $ | (3,524 | ) | |||||
Weighted average shares outstanding: | ||||||||||||||
Weighted average shares outstanding - basic | 69,965,814 | 69,743,897 | 69,628,135 | |||||||||||
Effect of dilutive common stock options | ||||||||||||||
and restricted stock | — | — | — | |||||||||||
Weighted average shares outstanding - diluted | 69,965,814 | 69,743,897 | 69,628,135 | |||||||||||
Basic and diluted (loss) earnings per share: | ||||||||||||||
Continuing operations | $ | (0.15 | ) | $ | (0.10 | ) | $ | (0.11 | ) | |||||
Discontinued Operations | $ | (0.01 | ) | $ | (0.15 | ) | $ | 0.06 | ||||||
Net loss | $ | (0.16 | ) | $ | (0.25 | ) | $ | (0.05 | ) | |||||
Outstanding options to purchase approximately 3,455,000, 5,171,000 and 4,028,000 shares of the Company's common stock were excluded from the calculation of diluted (loss) earnings per share for the years ended December 31, 2013, 2012 and 2011, respectively, because their exercise prices exceeded the average market price of the Company's common stock for such periods and therefore were antidilutive. | ||||||||||||||
(n) | Use of Estimates | |||||||||||||
The preparation of the accompanying consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions about future events. These estimates and the underlying assumptions affect the amounts of assets and liabilities reported, disclosures about contingent assets and liabilities, and reported amounts of revenues and expenses. Such estimates include the valuation of accounts receivable as well as the Holdback Amount, property, plant and equipment, deferred tax assets and the assessment of contingencies, among others. These estimates and assumptions are based on the Company’s best estimates and judgment. The Company evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, which the Company believes to be reasonable under the circumstances. The Company adjusts such estimates and assumptions when facts and circumstances dictate. As future events and their effects cannot be determined with precision, actual results could differ significantly from these estimates. Changes in those estimates will be reflected in the consolidated financial statements in future periods. | ||||||||||||||
(o) | Concentration of Credit Risk | |||||||||||||
The Company’s accounts receivable are due primarily from healthcare and insurance companies. As of December 31, 2013, there were three customer balances that each accounted for more than 10% of the total consolidated accounts receivable. The accounts receivable balance for these three customers represented approximately 42% of total consolidated accounts receivable as of December 31, 2013. For the year ended December 31, 2013, there was one customer in the Health and Wellness segment that exceeded 10% of revenue from continuing operations. For the year ended December 31, 2012, there were two customers in the Health and Wellness segment that exceeded 10% of revenue from continuing operations. For the year ended December 31, 2011, no one customer accounted for more than 10% of the revenue from continuing operations. As of December 31, 2012, no one customer accounted for more than 10% of the total consolidated accounts receivable. |
Liquidity
Liquidity | 12 Months Ended |
Dec. 31, 2013 | |
Liquidity [Abstract] | ' |
Liquidity | ' |
Liquidity | |
The Company’s primary sources of liquidity are cash and cash equivalents and the 2013 Loan and Security Agreement. At December 31, 2013, the Company had $4.0 million cash and cash equivalents, $8.6 million of working capital and no outstanding debt. | |
For the three years ended December 31, 2013, 2012 and 2011, the Company incurred losses from continuing operations of $10.3 million, $7.1 million and $7.8 million, respectively. Restructuring charges of continuing operations were $0.8 million, $0.6 million and $0.03 million, respectively, for the years ended December 31, 2013, 2012 and 2011, respectively. The Company’s net cash used in operating activities for the year ended December 31, 2013 was $7.0 million, and includes offsetting positive cash flow impacts of changes in accounts receivable, accounts payable and accrued expenses most of which were related to the Portamedic service line that were retained subsequent to the sale of Portamedic. The Company believes that a significant portion of the net cash flow inflows provided by changes in working capital during the fourth quarter of 2013 is a result of the run off of the Portamedic working capital. The Company has managed its liquidity through the sale of Portamedic and a series of cost reduction and accounts receivable collection initiatives. | |
Holdback Related to the Sale of Portamedic | |
On September 30, 2013, the Company completed the sale of Portamedic. Approximately $2.0 million (“Holdback Amount”) of the purchase price was held back by the acquirer as security for the Company’s obligations under the agreements between the Company and the acquirer. (Refer to Note 5). The Holdback Amount includes two components of $1.0 million each. Subsequent to December 31, 2013, the Company received $0.8 million of the first Holdback Amount but the final amount to be collected has not yet been finalized as of the date of this Report. As of December 31, 2013, the Company has recorded the receivable at the amount it believes will be collected. There cannot be any assurance that the remaining Holdback Amounts will be collected by the Company. The Company anticipates finalization and collection on the second Holdback Amount in the second quarter of 2015. | |
2013 Loan and Security Agreement | |
In the first quarter of 2013, the Company entered into a three year 2013 Loan and Security Agreement, as amended on March 28, 2013 by the First Amendment, (collectively, the “2013 Loan and Security Agreement”), with Keltic Financial Partners II, LP (“Keltic Financial”) (see Note 9). Borrowings under the 2013 Loan and Security Agreement are to be used for working capital purposes and capital expenditures. The amount available for borrowing may be less than the $10 million under this facility at any given time due to the manner in which the maximum available amount is calculated. The Company has an available borrowing base subject to reserves established at the lender's discretion of 85% of Eligible Receivables (as defined in the 2013 Loan and Security Agreement) up to $10 million under this facility. Eligible Receivables do not include Heritage Labs receivables, certain Hooper Holmes Services receivables, and other receivables deemed ineligible by the lender. Eligible Receivables include only billed receivables and concentration limits such that borrowing capacity may be affected by the Company's billing and revenue cycles. As of December 31, 2013, the lender applied a discretionary reserve of $1.5 million. Available borrowing capacity, net of this discretionary reserve was $2.0 million based on Eligible Receivables as of December 31, 2013. As of December 31, 2013, there were no borrowings outstanding under the 2013 Loan and Security Agreement. | |
The sale of the discontinued Portamedic operations, which accounted for approximately 60-75% of Eligible Receivables prior to the sale date of September 30, 2013, resulted in a decrease in the Company's borrowing capacity. As such, the Company worked with Keltic Financial to reduce the reserve on eligible borrowings of $1.5 million to $0.5 million effective February 21, 2014. | |
The Company is also working with Keltic Financial to modify the financial covenants of the 2013 Loan and Security Agreement in an effort to be more in-line with the Company's operations and strategy going forward. If the Company is not able to successfully execute favorable amendments to the existing credit facility, the Company's borrowing capacity may be limited. | |
The 2013 Loan and Security Agreement contains various covenants, including financial covenants which required the Company to achieve a minimum EBITDA amount (earnings before interest expense, income taxes, depreciation and amortization) beginning with the twelve months ending June 30, 2014 as the first measurement date. The lender recently waived the minimum EBITDA covenants for the 2014 fiscal period. The Company continues to have limitations on the maximum amount of unfunded capital expenditures for each fiscal year. | |
Restructuring Initiatives | |
Certain costs presented in the financial statements, notably selling, general and administrative costs, may not be indicative of costs going forward because those costs have historically been shared among all service lines. For the year ended December 31, 2013, $10.0 million of such selling, general and administrative costs were allocated to discontinued operations. While the Company is attempting to reduce these costs for its continuing operations, there is no guarantee that costs allocated to discontinued operations will be eliminated or reduced in future periods. | |
Since the Company historically has not tracked accounts receivable, accounts payable and other accounts by service line, its service lines had customers and suppliers in common, and its continuing and discontinued operations shared certain selling, general and administrative services, the Company does not have reliable information for the historical impact of the discontinued Portamedic operations on the Company’s cash flows. However, the Company feels that without the discontinued Portamedic operations and with selling, general and administrative cost reductions, cash flow from operations will improve. | |
While the corporate headquarters are located in Basking Ridge, New Jersey as of December 31, 2013, the Company began relocating the headquarters to Olathe, Kansas, where the Health and Wellness facilities are located, in the fourth quarter of 2013. This relocation has been substantially completed in the first quarter of 2014. The Company also listed its Basking Ridge real estate for sale during the fourth quarter of 2013. Establishing a new team and transitioning functions to Kansas will take months and transition costs may be higher than expected. In addition, the sale of the Basking Ridge real estate may not occur when expected or for the amount expected, although the sale would provide additional liquidity not factored into management's assessment of liquidity. The Company has received purchase offers on the real estate, but has not reached an agreement with a potential buyer. Keltic Financial has consented to the sale of the real estate. | |
Other Considerations | |
The Company's Heritage Labs segment shared some customers with the discontinued Portamedic operations. While not all Heritage Labs life insurance samples originated from Portamedic exams, the sale of the Portamedic service line may have an adverse impact on life insurance related lab testing and kit sale volumes. | |
The Company's Health and Wellness business sells through wellness, disease management and insurance companies who ultimately have the relationship with the end customer. The Company's current services are aggregated with its partners' offerings to provide a total solution. As such, the Company's success is largely dependent on that of its partners. | |
Through the increased focus on the Health and Wellness sector, the Company believes it will be able to capitalize on the opportunities that exist in the Health and Wellness sector given the macro-economic focus on health care costs and improving the efficiency of health care delivery in the United States to grow revenue. | |
If the Company is not able to realize the benefits from the consolidation in Kansas and control the costs of transition, reduce its selling, general and administrative costs as it seeks to streamline operations and improve efficiency, grow the Health and Wellness revenue and improve its gross profit through increased revenue and cost reduction initiatives, the Company may not have sufficient Eligible Receivables and the lender may increase reserves such that the Company may not be able to borrow under the 2013 Loan and Security Agreement. These and other factors could adversely affect liquidity and the Company's ability to generate cash flow in the future. | |
Based on the Company's anticipated level of future revenues and gross profit, collection of the first of the two Holdback Amounts, restructuring initiatives, and the Company's existing cash, cash equivalents, working capital and credit facility, the Company believes it has sufficient funds to meet its cash needs to fund operating expenses and capital expenditures for the twelve months following December 31, 2013. |
Impairment_of_Longlived_Assets
Impairment of Long-lived Assets | 12 Months Ended |
Dec. 31, 2013 | |
Goodwill and Intangible Assets Disclosure [Abstract] | ' |
Impairment of Long-lived Assets | ' |
Impairment of Long-lived Assets | |
The Company evaluates the recovery of its long-lived assets when events or changes in circumstances occur that indicate that the carrying value of assets may not be recoverable. During the year ended December 31, 2013, the Company recorded an impairment charge in continuing operations of $0.2 million, which is included in impairment in the accompanying consolidated statement of operations for the year ended December 31, 2013. The charge of $0.2 million for the year ended December 31, 2013 relates to the write-off software which is no longer expected to be utilized. | |
There were impairment charges of $0.2 million and $0.0 million, respectively, recorded in continuing operations for the years ended December 31, 2012 and 2011. Impairment charges in 2012 related to software associated with the Hooper Holmes Services segment. | |
Impairment in the consolidated statements of cash flows includes impairment of long-lived assets of discontinued operations of $0.2 million, $5.1 million and $0.2 million for the years ended December 31, 2013, 2012 and 2011, respectively. These impairment charges are included in (loss) income from discontinued operations in the consolidated statements of operations. |
ShareBased_Compensation
Share-Based Compensation | 12 Months Ended | ||||||||||
Dec. 31, 2013 | |||||||||||
Share-based Compensation [Abstract] | ' | ||||||||||
Share-based Compensation | ' | ||||||||||
Share-Based Compensation | |||||||||||
Employee Stock-Based Compensation Plan — On May 29, 2008, the Company's shareholders approved the 2008 Omnibus Employee Incentive Plan (the “2008 Plan”) providing for the grant of stock options, stock appreciation rights, non-vested stock and performance shares. The 2008 Plan provides for the issuance of an aggregate of 5,000,000 shares. During the three years ended December 31, 2013 options for the purchase of 325,000, 900,000 and 905,000 shares, respectively, were granted under the 2008 Plan. Also under the Plan for the year ended December 31, 2013, 205,532 shares of restricted stock were granted, which vest immediately but cannot be sold for one year from date of grant, to the Company's Chief Executive Officer as settlement for a discretionary bonus of $0.1 million. As of December 31, 2013, approximately 2,936,850 shares remain available for grant under the 2008 Plan. | |||||||||||
On May 24, 2011, the Company's shareholders approved the 2011 Omnibus Employee Incentive Plan (the "2011 Plan") providing for the grant of stock options and non-vested stock awards. On May 29, 2013, the Company's shareholders approved an amendment and restatement of the 2011 Plan which increases the number of shares of the Company's stock available for issuance from 1,500,000 shares to 3,500,000 (subject to adjustment as provided in the Amended and Restated Omnibus Plan). During the three years ended December 31, 2013, 2012 and 2011options for the purchase of 2,000,000, 1,225,000 and 75,000 shares, respectively, were granted under the 2011 Plan. As of December 31, 2013, the Company is authorized to grant share-based awards of approximately 1,375,250 shares under the 2011 Plan. | |||||||||||
Prior to the 2008 Plan, the Company’s shareholders had approved stock option plans providing for the grant of options for up to 2,400,000 shares of common stock in 1997, 2,000,000 shares in 1999 and 3,000,000 shares in 2002. Upon the adoption of the 2008 Plan, no further awards could be granted under these prior stock option plans. | |||||||||||
Options under the 2008 and 2011 Plans are granted at fair value on the date of grant, are exercisable in accordance with a vesting schedule specified in the grant agreement, and have contractual lives of 10 years from the date of grant. Options to purchase 500,000 of the Company's stock granted to certain executives of the Company in December 2010 vested 50% on each of the first and second anniversaries of the grant. Options to purchase 325,000, 700,350 and 132,700 of the Company's stock granted to certain executives of the Company in September 2013, July 2012 and July 2011, respectively, vest one-third on each of the first, second and third anniversaries of the grant. Options to purchase 2,000,000 shares of the Company's stock granted to the Chief Executive Officer of the Company in September 2013, vest 25% upon receipt of the grant and 25% on the first, second, and third anniversaries of the grant. All other options granted by the Company vest 25% on each of the second through fifth anniversaries of the grant. | |||||||||||
The fair value of each stock option granted during the year was estimated on the date of grant using the Black-Scholes option pricing model with the following weighted average assumptions: | |||||||||||
2013 | 2012 | 2011 | |||||||||
Expected life (years) | 5.4 | 5.5 | 5.5 | ||||||||
Expected volatility | 89.6 | % | 92.4 | % | 92.6 | % | |||||
Expected dividend yield | — | — | — | ||||||||
Risk-free interest rate | 1.5 | % | 0.7 | % | 1.6 | % | |||||
Weighted average fair value of options granted during the year | $0.34 | $0.47 | $0.69 | ||||||||
The expected life of options granted is derived from the Company’s historical experience and represents the period of time that options granted are expected to be outstanding. Expected volatility is based on the Company’s long-term historical volatility. The risk-free interest rate for periods within the contractual life of the options is based on the U.S. Treasury yield curve in effect at the time of the grant. | |||||||||||
The following table summarizes stock option activity for the year ended December 31, 2013: | |||||||||||
Weighted | |||||||||||
Weighted Average | Average Remaining | Aggregate Intrinsic | |||||||||
Number of Shares | Exercise Price Per Share | Contractual Life (years) | Value (in thousands) | ||||||||
Outstanding at December 31, 2012 | 6,429,250 | $1.28 | |||||||||
Granted | 2,325,000 | $0.47 | |||||||||
Exercised | (182,930 | ) | 0.39 | ||||||||
Expired | (2,514,070 | ) | $1.96 | ||||||||
Forfeited | (1,906,700 | ) | $0.54 | ||||||||
Outstanding at December 31, 2013 | 4,150,550 | $0.75 | 8.3 | $2 | |||||||
Exercisable at December 31, 2013 | 1,907,350 | $1.04 | 6.8 | $2 | |||||||
The aggregate intrinsic value disclosed in the table above represents the difference between the Company’s closing stock price on the last trading day of 2013 (December 31, 2013) and the exercise price, multiplied by the number of in-the-money stock options for each category. | |||||||||||
For the year ended December 31, 2013, 173,050 and 9,880 stock options valued with a weighted average exercise price of $0.38 and $0.65 were exercised under the 2008 Plan and 2011 Plan, respectively. No stock options were exercised during the years ended December 31, 2012 and 2011. | |||||||||||
Options for the purchase of 1,498,850, 1,176,150 and 1,110,625 shares of common stock vested during the years ended December 31, 2013, 2012 and 2011, respectively, and the aggregate fair value at grant date of these options was $0.7 million, $0.7 million and $0.8 million, respectively. As of December 31, 2013, there was approximately $0.6 million of unrecognized compensation cost related to stock options which is expected to be recognized over a weighted average period of 2.5 years. Shares issued upon stock option exercises may be made available from authorized but unissued common stock or from treasury shares. | |||||||||||
In July 2009, an aggregate of 500,000 shares of non-vested stock were granted under the 2008 Plan. The fair value of these non-vested stock awards was based on the grant date fair value and amounted to $0.45 per share. The shares vest as follows: 25% after two years and 25% on each of the next three anniversary dates thereafter. As of December 31, 2013, an aggregate of 343,750 shares of such non-vested stock were forfeited and 150,000 shares were vested. In July 2011, an aggregate of 305,000 shares of non-vested stock were granted under the 2008 Plan. The fair value of these non-vested stock awards was based on the grant date fair value and amounted to $1.06 per share. As of December 31, 2013 an aggregate of 141,400 shares of such non-vested stock were forfeited and 155,100 vested. The shares vest as follows: 33% on each of the first and second anniversary dates and 34% on the third anniversary. As of December 31, 2013, there was approximately $0.01 million of total unrecognized compensation cost related to non-vested stock awards. The cost is expected to be recognized over 0.6 years. | |||||||||||
The Company’s initial accruals for share-based compensation expense are based on the estimated number of instruments for which the requisite service is expected to be rendered. Therefore, the Company is required to incorporate the probability of pre-vesting forfeitures in determining the number of options and restricted stock that are estimated to vest. The forfeiture rate is based on historical forfeiture experience. The Company monitors employee termination patterns to estimate forfeiture rates. | |||||||||||
Employee Stock Purchase Plan — The Company’s 2004 Employee Stock Purchase Plan (the "2004 Plan”) provides for the granting of purchase rights for up to 2,000,000 shares of Company stock to eligible employees of the Company. The 2004 Plan provides employees with the opportunity to purchase shares on the date 13 months from the grant date (“the purchase date”) at a purchase price equal to 95% of the closing price of the Company’s common stock on the NYSE MKT on the grant date. During the period between the grant date and the purchase date, up to 10% of a participating employee's compensation, not to exceed $0.025 million, is withheld to fund the purchase of shares. Employees can cancel their purchases at any time during the period without penalty. In February 2011, purchase rights for approximately 279,800 shares were granted with an aggregate fair value of $0.05 million, based on the Black-Scholes pricing model. The February 2011 offering concluded in March 2012 and, in accordance with the 2004 Plan's automatic termination provision, no shares were issued. In February 2012, under the 2004 Plan, purchase rights for approximately 273,000 shares were granted with an aggregate fair value of $0.05 million, based on the Black Scholes option pricing model. The February 2012 offering period concluded in March 2013 and, in accordance with the 2004 Plan's automatic termination provision, no shares were issued. In February 2013, under the 2004 Plan, purchase rights for approximately 233,000 shares were granted with an aggregate fair value of $0.03 million, based on the Black-Scholes option pricing model. The February 2013 offering period will conclude in March 2014. On May 29, 2013, the Company's shareholders approved an amendment and restatement of the Employee Stock Purchase Plan (2004), to be effective January 1, 2014 (as amended and restated the "2014 Plan"). The aggregate number of shares of the Company's common stock available for purchase under the 2014 Plan is 2,000,000. Unless terminated earlier by the Board of Directors, the 2014 Plan will terminate December 31, 2024. | |||||||||||
Other Stock Awards — On May 30, 2007, the Company’s shareholders approved the Hooper Holmes, Inc. 2007 Non-Employee Director Restricted Stock Plan (the “2007 Plan”), which provides for the automatic grant, on an annual basis for 10 years, of shares of the Company’s stock to the Company's non-employee directors. The total number of shares that may be awarded under the 2007 Plan is 600,000. As of December 31, 2013, the Company is authorized to grant restricted stock awards of approximately 360,000 shares under the 2007 Plan. Effective June 1, 2007, each non-employee member of the Board other than the non-executive chair receives 5,000 shares annually and the non-executive chair receives 10,000 shares annually of the Company’s stock with such shares vesting immediately upon issuance. The Company believes that the shares awarded under the 2007 Plan are “restricted securities” as defined in SEC Rule 144 under the Securities Act of 1933, as amended. The Company filed a Registration Statement on Form S-8 with respect to the 2007 Plan on April 16, 2008. The directors who receive shares under the 2007 Plan are “affiliates” as defined in Rule 144 of the Securities Act of 1933, as amended, and thus remain subject to the applicable provisions of Rule 144. In addition, the terms of the awards (whether or not restricted) specify that the shares may not be sold or transferred by the recipient until the director ceases to serve on the Board or, if at that time the director has not served on the Board for at least four years, on the fourth anniversary of the date the director first became a Board member. For the years ended December 31, 2013, 2012 and 2011, shares awarded under the 2007 Plan totaled 30,000, 30,000 and 30,000, respectively. The fair value of these stock awards was based on the grant date market value and totaled $0.02 million, $0.02 million and $0.02 million, respectively. | |||||||||||
The Company recorded $0.9 million, $0.7 million and $0.6 million of share-based compensation expense in selling, general and administrative expenses for each of the years ended December 31, 2013, 2012 and 2011, respectively, related to stock options, non-vested stock, restricted stock awards and the 2004 Plan, of which $0.8 million, $0.7 million and $0.6 million related to continuing operations for the years ended December 31, 2013, 2012 and 2011, respectively. In connection with the resignation of former executive officers, the Company reversed previously recorded share-based compensation expense totaling $0.2 million during the year ended December 31, 2013. The reversals were recorded in restructuring charges (See Note 6). There were no reversals during 2012 or 2011. |
Discontinued_Operations
Discontinued Operations | 12 Months Ended | |||||||||
Dec. 31, 2013 | ||||||||||
Discontinued Operations and Disposal Groups [Abstract] | ' | |||||||||
Discontinued Operations | ' | |||||||||
Discontinued Operations | ||||||||||
On September 30, 2013, the Company completed the sale of certain assets comprising the Portamedic service line to Piston Acquisition, Inc., a subsidiary of American Para Professional Systems, Inc., (“Piston”). Pursuant to the terms of the Asset Purchase Agreement, the Company sold assets associated with the Portamedic service line to Piston, including, among other things, fixed assets, inventory and intellectual property, and Piston assumed certain specified liabilities. The adjusted purchase price (the "Purchase Price") was approximately $8.1 million in cash, adjusted from $8.4 million at announcement due to changes in working capital. Approximately $2.0 million of the Purchase Price was held back (the "Holdback Amount") by Piston as security for the obligations under the Asset Purchase Agreement and certain other agreements between the Company and Piston. | ||||||||||
The Holdback Amount includes two components. The first holdback is $1.0 million, subject to adjustments, and will be released in total as follows: within three business days after the date on which final closing adjustments for inventory and other current assets are determined and paid (the “Closeout Date”). The remaining $1.0 million of the Holdback Amount, less any deductions or adjustments with respect to fixed assets, indemnification claims and any amounts in respect of any indemnification claims then in dispute, will be paid on the first anniversary of the Closeout Date. In the third quarter of 2013, the Company recorded receivables of $1.0 million in other current assets and $1.0 million in other long-term assets related to the Holdback Amount, totaling $2.0 million. As of December 31, 2013, the Company has recorded the receivable at the amount it believes will be collected. Subsequent to December 31, 2013, the Company received $0.8 million of the first Holdback Amount but the final amount to be collected has not yet been finalized as of the date of this Report. There cannot be any assurance that the remaining the Holdback Amounts will be collected by the Company. The Company anticipates finalization and collection on the second Holdback Amount in the second quarter of 2015. | ||||||||||
The Company decided to sell its under-performing Portamedic service line and shift its focus towards the growth of its remaining health care segments. In connection with the sale, the Company received $6.1 million of cash proceeds in connection with the sale and incurred $1.0 million of financial advisory, legal and accounting fees during the year ended December 31, 2013, of which $0.8 million was paid during the year ended December 31, 2013. | ||||||||||
The following summarizes the operating results of Portamedic and the gain on sale of Portamedic which are reported in discontinued operations in the accompanying consolidated statements of operations for the years ended December 31, 2013, 2012 and 2011: | ||||||||||
2013 | 2012 | 2011 | ||||||||
Revenue | $ | 66,467 | $ | 100,400 | $ | 111,417 | ||||
(Loss) income from discontinued operations | $ | (4,450 | ) | $ | (10,586 | ) | $ | 4,216 | ||
Gain on sale of Portamedic | $ | 3,355 | $ | — | $ | — | ||||
Income taxes relating to the operations of Portamedic were less than $0.1 million for each period | ||||||||||
presented and there were no income taxes on the gain on the sale due to the availability of net operating loss carry forwards with full valuation allowance. | ||||||||||
The assets and liabilities of the discontinued Portamedic operations are presented separately under the captions “Assets held for sale” and “Liabilities held for sale,” respectively, in the accompanying consolidated balance sheet as of December 31, 2012 and consist of the following: | ||||||||||
(in thousands) | 31-Dec-12 | |||||||||
Assets held for sale: | ||||||||||
Inventories | $ | 941 | ||||||||
Other current assets | 400 | |||||||||
Property, plant and equipment, net | 2,080 | |||||||||
Other assets | 225 | |||||||||
Total assets | $ | 3,646 | ||||||||
Liabilities held for sale: | ||||||||||
Deferred rent | 104 | |||||||||
Capital leases | 116 | |||||||||
Total liabilities | $ | 220 | ||||||||
In connection with the 2008 sale of the Claims Evaluation Division ("CED"), the Company was released as the primary obligor for certain lease obligations acquired but remains secondarily liable in the event the buyer defaults through the lease term which expires in July 2015. At December 31, 2013, the Company maintained a liability of $0.05 million for this lease obligation, which has a maximum exposure of $0.2 million. During the years ended December 31, 2013, 2012 and 2011, the Company reduced liabilities related to CED by $0.08 million, $0.07 million and $0.06 million, respectively. The corresponding gains are reported in the accompanying consolidated statement of operations in discontinued operations for the years ended December 31, 2013, 2012 and 2011. |
Restructuring_Charges
Restructuring Charges | 12 Months Ended | |||||||||||||||
Dec. 31, 2013 | ||||||||||||||||
Restructuring Charges [Abstract] | ' | |||||||||||||||
Restructuring Charges | ' | |||||||||||||||
Restructuring Charges | ||||||||||||||||
Following is a summary of the restructuring charges for the year ended December 31, 2013 | ||||||||||||||||
As of | As of | |||||||||||||||
(In millions) | 31-Dec-12 | Charges | Payments | 31-Dec-13 | ||||||||||||
Severance | $ | — | $ | 1.3 | $ | (0.8 | ) | $ | 0.5 | |||||||
Lease closure obligation | 0.7 | 0.6 | (0.9 | ) | 0.4 | |||||||||||
Total | $ | 0.7 | $ | 1.9 | $ | (1.7 | ) | $ | 0.9 | |||||||
Restructuring Charges | ||||||||||||||||
During the year ended December 31, 2013, the Company recorded restructuring charges of $1.9 million, of which $0.8 million was recorded in continuing operations and $1.1 million was recorded in discontinued operations. Restructuring charges in continuing operations consist of severance related to the resignation of former executives and other employee severance. Restructuring charges in discontinued operations include lease closure costs as well as severance. | ||||||||||||||||
During the year ended December 31, 2012, the Company recorded restructuring charges of $2.7 million, of which $0.6 million was recorded in continuing operations and $2.1 million was recorded in discontinued operations. Restructuring charges in continuing operations consist of employee severance. Restructuring charges in discontinued operations consist of $1.2 million related to branch closure costs and $0.9 million for severance. The restructuring charges in 2012 related to the deployment of a new service delivery model for the discontinued Portamedic operations. | ||||||||||||||||
During the year ended December 31, 2011, the Company recorded restructuring charges of $0.3 million. Restructuring charges of $0.03 million and $0.27 million were recorded in continuing operations and discontinued operations, respectively, and related to severance and branch closure costs. | ||||||||||||||||
Restructuring Accrual | ||||||||||||||||
At December 31, 2013, there was a total of $0.9 million of accrued restructuring charges recorded in the Company's consolidated balance sheet. There was $0.87 million recorded in accrued expenses and $0.08 million recorded in other long-term liabilities, related to long-term branch closure costs, as of December 31, 2013. |
Property_Plant_and_Equipment
Property, Plant and Equipment | 12 Months Ended | ||||||||||
Dec. 31, 2013 | |||||||||||
Property, Plant and Equipment [Abstract] | ' | ||||||||||
Property, Plant and Equipment | ' | ||||||||||
Property, Plant and Equipment | |||||||||||
Property, plant and equipment, at cost, consists of the following: | |||||||||||
Estimated | |||||||||||
December 31, | Useful Life | ||||||||||
2013 | 2012 | In Years | |||||||||
Land and improvements | $ | — | $ | 639 | |||||||
Building and leasehold improvements | 1,864 | 6,935 | 3 – 45 | ||||||||
Furniture, fixtures and equipment | 9,542 | 9,650 | 2 – 10 | ||||||||
Software | 4,612 | 3,605 | 1 – 7 | ||||||||
16,018 | 20,829 | ||||||||||
Less accumulated depreciation and amortization | 12,257 | 15,195 | |||||||||
Total | $ | 3,761 | $ | 5,634 | |||||||
During the years ended December 31, 2013, 2012 and 2011, the Company determined that the carrying values of certain long-lived assets were impaired (see Note 3). | |||||||||||
As of December 31, 2013, the Basking Ridge, NJ real estate was classified as assets held for sale. The Board authorized the sale of the real estate during the fourth quarter of 2013, and the Company received approval from Keltic Financial to sell the property. As a result, the land and building owned in Basking Ridge, NJ of $0.7 million are recorded as assets held for sale at December 31, 2013. |
Accrued_Expenses
Accrued Expenses | 12 Months Ended | ||||||||
Dec. 31, 2013 | |||||||||
Payables and Accruals [Abstract] | ' | ||||||||
Accrued Expenses | ' | ||||||||
Accrued Expenses | |||||||||
Accrued expenses consisted of the following: | |||||||||
December 31, | |||||||||
2013 | 2012 | ||||||||
Accrued wages | $ | 332 | $ | 1,292 | |||||
Reserve for unclaimed property | 910 | 752 | |||||||
Restructure reserves | 870 | 444 | |||||||
Other accrued expenses | 1,924 | 1,951 | |||||||
$ | 4,036 | $ | 4,439 | ||||||
Loan_and_Security_Agreements
Loan and Security Agreements | 12 Months Ended | |
Dec. 31, 2013 | ||
Debt Disclosure [Abstract] | ' | |
Loan and Security Agreements | ' | |
Loan and Security Agreements | ||
In the first quarter of 2013, the Company entered into a three year 2013 Loan and Security Agreement, as amended on March 28, 2013 by the First Amendment, with Keltic Financial. Borrowings under the 2013 Loan and Security Agreement are to be used for working capital purposes and capital expenditures. The amount available for borrowing may be less than the $10 million under this facility at any given time due to the manner in which the maximum available amount is calculated. The Company has an available borrowing base subject to reserves established at the lender's discretion of 85% of Eligible Receivables up to $10 million under this facility. Eligible Receivables do not include Heritage Labs receivables, certain Hooper Holmes Services receivables, and other receivables deemed ineligible by Keltic Financial. Eligible Receivables include only billed receivables such that borrowing capacity may be affected by the Company's billing cycles. As of December 31, 2013, the lender applied a discretionary reserve of $1.5 million. Available borrowing capacity, net of this discretionary reserve was $2.0 million based on Eligible Receivables as of December 31, 2013. As of December 31, 2013, there were no borrowings outstanding under the 2013 Loan and Security Agreement. | ||
On March 28, 2013, the Company entered into the First Amendment to the 2013 Loan and Security Agreement. In addition to increases in the annual facility fee, monthly collateral management fee and early termination fees, there were revisions to collateral and the first measurement date of the EBITDA covenant was changed. In connection with the amendment, the Company paid fees of $0.2 million. | ||
Interest on revolving credit loans is calculated based on the greatest of (i) the annualized prime rate plus 2.75%, (ii) the 90 day LIBOR rate plus 5.25%, and (iii) 6% per annum. The interest rate on the 2013 Loan and Security Agreement was 6.00% as of December 31, 2013. In connection with the 2013 Loan and Security Agreement, the Company incurred a commitment fee of $0.1 million and other debt issue costs totaling $0.9 million. The Company is also obligated to pay, on a monthly basis in arrears, an annual facility fee equal to 1% of the revolving credit limit of $10 million. During the year ended December 31, 2013, in connection with the 2013 Loan and Security Agreement, the Company incurred $0.1 million in facility fees. | ||
The revolving credit loans are payable in full, together with all accrued interest and fees, on February 28, 2016. The 2013 Loan and Security Agreement provides for the prepayment of the entire outstanding balance of the revolving credit loans. The Company would be required to pay an early termination fee equal to 3% of the revolving credit limit if the termination occurs prior to February 28, 2015, and 2% if the termination occurs after February 28, 2015 but prior to February 28, 2016. | ||
As security for payment and other obligations under the 2013 Loan and Security Agreement, the Company granted Keltic Financial a security interest in all of its, and its subsidiary guarantors, existing and after-acquired property, including receivables (which are subject to a lockbox account arrangement), inventory, equipment and the Basking Ridge, NJ real estate. The aforementioned security interest is collectively referred to herein as the “collateral”. | ||
Pursuant to the terms of the 2013 Loan and Security Agreement, Keltic Financial, at its sole discretion, may establish reserves with respect to (a) any event which in Keltic Financial's reasonable determination diminishes the value of any collateral or (b) any of the Company's contingent liabilities. A reserve may reduce the aggregate amount of indebtedness that may be incurred under the 2013 Loan and Security Agreement. | ||
The 2013 Loan and Security Agreement contains covenants that, among other things, restricts the Company's ability, and that of its subsidiaries, to: | ||
• | pay any dividends or distributions on, or redeem or retire any shares of any class of capital stock or other equity interests; | |
• | incur additional indebtedness or otherwise become liable for the indebtedness, except for transactions in the ordinary course of business; | |
• | permit a change of control of the board of directors and certain senior management positions of the Company without prior consent of Keltic Financial; | |
• | sell or otherwise dispose of any of the Company's assets, other than in the ordinary course of business; | |
• | create liens or encumbrances on the Company's assets; and | |
• | enter into transactions with any of its affiliates on other than an arm's-length or no less favorable basis. | |
Keltic Financial consented to the change in CEO and CFO that occurred during 2013 as well as the sale of Portamedic. There were no waiver or amendment fees paid or associated with these consents. | ||
The 2013 Loan and Security Agreement contains various covenants, including financial covenants which required the Company to achieve a minimum EBITDA amount (earnings before interest expense, income taxes, depreciation and amortization) beginning with the twelve months ending June 30, 2014 as the first measurement date. The lender recently waived the minimum EBITDA covenants for the 2014 fiscal period. The Company continues to have limitations on the maximum amount of unfunded capital expenditures for each fiscal year. | ||
The failure of the Company or any subsidiary guarantor to comply with any of the covenants or the breach of any of its or their representations and warranties, contained in the 2013 Loan and Security Agreement, constitutes an event of default under the agreement. In addition, the 2013 Loan and Security Agreement provides that "Events of Default" include the occurrence or failure of any event or condition that, in Keltic Financial's sole judgment, could have a material adverse effect (i) on the business, operations, assets, management, liabilities or condition of the Company, (ii) in the value, collectability or salability of the collateral, or (iii) on the ability of the Company and its subsidiary guarantors to perform under the 2013 Loan and Security Agreement. | ||
2009 Loan and Security Agreement | ||
Prior to February 28, 2013, the Company maintained a loan and security agreement (the “2009 Loan and Security Agreement”) with TD Bank, N.A. (“TD Bank”), which was scheduled to expire on March 8, 2013. On February 28, 2013, in conjunction with entering into a new three year 2013 Loan and Security Agreement with Keltic Financial Partners II, LP, the Company terminated the 2009 Loan and Security Agreement with TD Bank. During the years ended December 31, 2012 and 2011, in connection with the TD Bank 2009 Loan and Security Agreement, the Company incurred unused line fees of $0.1 million and $0.1 million, respectively. In addition, the Company was required to pay annual loan fees of $0.1 million for both 2012 and 2011. |
Commitments_and_Contingencies
Commitments and Contingencies | 12 Months Ended | ||||
Dec. 31, 2013 | |||||
Commitments and Contingencies Disclosure [Abstract] | ' | ||||
Commitments and Contingencies | ' | ||||
Commitments and Contingencies | |||||
The Company leases its new corporate headquarters, continuing laboratory facility and operations centers under operating leases which expire in various years through 2018. These leases generally contain renewal options and require the Company to pay all executory costs (such as property taxes, maintenance and insurance). The Company also leases copiers and other miscellaneous equipment. These leases expire in various years through 2017. | |||||
The Company is still the primary lessee under operating leases for 16 Portamedic branch offices, which are subleased by the acquirer of the former Portamedic business. The acquirer pays 100% of the rent and other executory costs for these 16 offices in the form of a contractual obligation for the remaining lease term. If the Company is unable to assign these leases to the acquirer of the former Portamedic business, the Company will let the leases expire with no intent of renewal. | |||||
In addition, the Company is still the primary lessee under 21 operating leases related to former Portamedic offices not utilized for continuing operations and as such related costs are recorded in the reporting for discontinued operations. The Company has recorded a branch closure obligation of $0.3 million as of December 31, 2013 related to these leases. | |||||
The table below presents future minimum lease payments for operating leases (with initial or remaining terms in excess of one year) as of December 31, 2013 and includes leases from both continuing and discontinued operations, as described above. | |||||
Year ending December 31, | Operating | ||||
Leases | |||||
2014 | $ | 2,535 | |||
2015 | 1,806 | ||||
2016 | 1,524 | ||||
2017 | 1,378 | ||||
2018 | 1,104 | ||||
Thereafter | — | ||||
Total minimum lease payments | $ | 8,347 | |||
Rental expense under operating leases of continuing operations totaled $0.7 million, $2.0 million and $1.9 million in 2013, 2012 and 2011, respectively. Rental expense in 2013 is net of sublease rental income from the acquirer of the former Portamedic operations of $0.2 million. | |||||
The Company has employment retention or change in control agreements with the executive officers of the Company for a one year period from the date a change in control occurs as further defined in the agreements. | |||||
In the past, some federal and state agencies have claimed that the Company improperly classified its health professionals as independent contractors for purposes of federal and state unemployment and/or worker's compensation tax laws and that the Company was therefore liable for taxes in arrears, or for penalties for failure to comply with their interpretation of the laws. There are no assurances that the Company will not be subject to similar claims in the future. |
Litigation
Litigation | 12 Months Ended |
Dec. 31, 2013 | |
Commitments and Contingencies Disclosure [Abstract] | ' |
Litigation | ' |
Litigation | |
On April 23, 2012, a complaint was filed against the Company in U.S. District Court for the District of New Jersey on behalf of a purported class of employee examiners alleging, among other things, that the Company had failed to pay overtime compensation to certain employees as required by federal law. On May 24, 2012, a related complaint was filed against the Company in the same court alleging, among other things, that the Company similarly failed to pay overtime compensation to a purported class of certain independent contractor examiners who, the complaint alleges, should be treated as employees for purposes of federal law. The complaints seek award of an unspecified amount of allegedly unpaid overtime wages to certain examiners. The Company believes the allegations in the cases are without merit, has filed answers in both cases denying the substantive allegations therein. By Consent Order filed March 11, 2013, the court approved a settlement of $0.05 million between the Company and the named plaintiffs in the employee case, and the case was dismissed with prejudice. Preliminary discovery and motion practice are being conducted in the contractor case. The claim is not covered by insurance, and the Company is incurring legal costs to defend the litigation. This matter relates to the former Portamedic service line for which the Company retained liability. | |
On July 30, 2013, a complaint was filed against the Company in the California Superior Court, San Bernadino County, on behalf of a putative class of employees alleging, among other things, that the Company failed to pay wages and other compensation as required by state law. The complaint seeks award of an unspecified amount of damages and penalties. The Company has denied all of the allegations in the case and believes them to be without merit. In January 2014, the Superior Court referred the parties to mediation and set a mediation completion date for August 30, 2014. The Superior Court also set a trial date of August 10, 2015. The claim is not covered by insurance, and as a result, the Company is incurring legal costs to defend the litigation. | |
The Company is a party to a number of other legal actions arising in the ordinary course of its business. In the opinion of management, the Company has substantial legal defenses and/or insurance coverage with respect to all of its pending legal actions. Accordingly, none of these actions is expected to have a material adverse effect on the Company’s liquidity, its consolidated results of operations or its consolidated financial position. |
Income_Taxes
Income Taxes | 12 Months Ended | ||||||||||||
Dec. 31, 2013 | |||||||||||||
Income Tax Disclosure [Abstract] | ' | ||||||||||||
Income Taxes | ' | ||||||||||||
Income Taxes | |||||||||||||
The components of the income tax provision are as follows: | |||||||||||||
2013 | 2012 | 2011 | |||||||||||
Federal - current | $ | — | $ | — | $ | — | |||||||
State and local - current | 19 | 23 | 36 | ||||||||||
$ | 19 | $ | 23 | $ | 36 | ||||||||
The following reconciles the “statutory” federal income tax rate to the effective income tax rate: | |||||||||||||
2013 | 2012 | 2011 | |||||||||||
Computed "expected" income tax benefit | (35 | )% | (35 | )% | (35 | )% | |||||||
Reduction (increase) in income tax benefit and increase (reduction) in income tax expense resulting from: | |||||||||||||
State tax, net of federal benefit | — | — | — | ||||||||||
Change in federal valuation allowance | 35 | 35 | 35 | ||||||||||
Other | — | — | — | ||||||||||
Effective income tax rate | — | % | — | % | — | % | |||||||
The tax effects of temporary differences that give rise to the deferred tax assets and liabilities at December 31, 2013 and 2012 are as follows: | |||||||||||||
2013 | 2012 | ||||||||||||
Deferred tax assets: | |||||||||||||
Receivable allowance | $ | 59 | $ | 259 | |||||||||
Goodwill | 4,238 | 6,459 | |||||||||||
Restructuring accrual | 370 | 215 | |||||||||||
Impairment and accumulated depreciation | — | 675 | |||||||||||
Intangible assets | 845 | 1,309 | |||||||||||
Compensation expense | 1,518 | 1,399 | |||||||||||
Federal net operating loss carryforward | 48,990 | 40,773 | |||||||||||
State net operating loss carryforward | 5,756 | 5,109 | |||||||||||
AMT credit carry forward | — | 157 | |||||||||||
Accrued expenses | 25 | 65 | |||||||||||
Deferred rent | 131 | 177 | |||||||||||
Other | 167 | 182 | |||||||||||
Gross deferred tax assets | $ | 62,099 | $ | 56,779 | |||||||||
Valuation allowance | (61,500 | ) | (56,779 | ) | |||||||||
$ | 599 | $ | — | ||||||||||
Deferred tax liabilities: | |||||||||||||
Impairment and accumulated depreciation | (599 | ) | — | ||||||||||
Gross deferred tax liabilities | (599 | ) | — | ||||||||||
Net deferred tax assets | $ | — | $ | — | |||||||||
The Company has significant deferred tax assets attributable to tax deductible intangibles and federal and state net operating loss carryforwards, which may reduce taxable income in future periods. Based on the continued decline in revenues, the cumulative tax and operating losses, the lack of taxes in the carryback period, and the uncertainty surrounding the extent or timing of future taxable income, the Company does not believe it will realize the tax benefits of its deferred tax assets. Accordingly, the Company continues to record a full valuation allowance on its net deferred tax assets as of December 31, 2013 and 2012. During 2012, capital loss carryforwards of $2.0 million, which had a full valuation allowance, expired and were written off. | |||||||||||||
There was no federal tax expense recorded in the years ended December 31, 2013, 2012 and 2011. The income tax expense recorded for the years ended December 31, 2013 and 2012 reflects a state tax liability to one state. The income tax expense recorded in the year ended December 31, 2011 is primarily due to taxes on gross revenues related to two states, a liability, including interest, for amended tax returns for one of these states for the years 2006 through 2008 and the true-up of the 2010 tax provision for two states. | |||||||||||||
As of December 31, 2013, no amounts were recorded for uncertain tax positions or for the payment of interest or penalties. The Company is under examination by the IRS and expects to reach a conclusion with the IRS for tax year 2011 without a material effect. State income tax returns for the year 2009 and forward are subject to examination. | |||||||||||||
As of December 31, 2013, the Company had U.S. federal and state net operating loss carryforwards of approximately $140.0 million and $127.2 million, respectively. The net operating loss carryforwards, if not utilized, will expire in the years 2014 through 2033. |
Capital_Stock
Capital Stock | 12 Months Ended |
Dec. 31, 2013 | |
Stockholders' Equity Note [Abstract] | ' |
Capital Stock | ' |
Capital Stock | |
The 2013 Loan and Security Agreement prohibits the Company from repurchasing or retiring shares of its common stock and paying dividends (see Note 9). The Company did not repurchase any shares of its common stock in 2013, 2012 and 2011. |
401k_Savings_and_Retirement_Pl
401(k) Savings and Retirement Plan | 12 Months Ended |
Dec. 31, 2013 | |
Compensation and Retirement Disclosure [Abstract] | ' |
401(k) Savings and Retirement Plan | ' |
401(k) Savings and Retirement Plan | |
The Company’s 401(k) Savings and Retirement Plan (the “401(k) Plan”) is available to all employees with at least one year of employment service, who have worked at least 1,000 hours in a service year and who are at least 21 years of age. There were no Company contributions related to the 401(k) Plan during the years ended December 31, 2013, 2012 and 2011. The Company’s common stock is not an investment option to employees participating in the 401(k) Plan. |
Segments
Segments | 12 Months Ended | ||||||||||||||||
Dec. 31, 2013 | |||||||||||||||||
Segment Reporting [Abstract] | ' | ||||||||||||||||
Segments | ' | ||||||||||||||||
Segments | |||||||||||||||||
Following the sale of the Portamedic service line, the Company reassessed its segment reporting to align with the information that the Company's chief operating decision maker regularly reviews since the sale of Portamedic. Beginning in the fourth quarter of 2013, the Company reports financial results in three segments: Health and Wellness (health risk assessments including biometric screenings), Heritage Labs (laboratory testing and kit assembly) and Hooper Holmes Services (health information services). Financial statement amounts have been recast to reflect the new segment determination for all periods presented in this Report, including revenues and costs previously reported as a part of discontinued Portamedic operations which have been reclassified to Hooper Holmes Services to conform to current period presentation. The determination of segment assets involves a degree of management judgment and estimates as the Company has not historically prepared balance sheets by service line. As of December 31, 2013, substantially all of the Company's services are provided within the United States, and substantially all of the Company's assets are located within the United States. | |||||||||||||||||
The table presented below provides disclosures by segment for the years ended December 31, 2013, 2012 and 2011. Intercompany revenue for the years ended December 31, 2013, 2012 and 2011 was $1.1 million, $2.1 million and $2.0 million, representing Heritage Lab revenue for kit sales to the discontinued Portamedic operations at arms' length sales prices. Heritage Lab also performs services to Health and Wellness. These services are recorded at Heritage Labs' cost directly within the Health and Wellness segment, and thus, no intercompany elimination is required. | |||||||||||||||||
2013 | Health and Wellness | Heritage Labs | Hooper Holmes Services | Unallocated Corporate | Total | ||||||||||||
Revenues | $ | 23,149 | $ | 11,390 | $ | 14,621 | $ | — | $ | 49,160 | |||||||
Depreciation and amortization expense | 655 | 423 | 260 | 508 | 1,846 | ||||||||||||
Operating income (loss) | 5 | 619 | (1,716 | ) | (8,664 | ) | (a) | (9,756 | ) | ||||||||
Capital expenditures | 347 | 56 | — | 122 | 525 | ||||||||||||
Segment assets | 6,937 | 4,094 | 1,994 | 8,621 | 21,646 | ||||||||||||
a) Unallocated corporate includes selling, general and administrative costs that the Company has not allocated to its segments. The method of allocating selling, general and administrative costs to Health and Wellness, Heritage Labs and Hooper Holmes Services did not change subsequent to the sale of Portamedic. Allocations that would have been made to Portamedic in the fourth quarter of 2013 if it had still been owned by the Company were made using previously budgeted amounts, which resulted in higher unallocated amounts in corporate during the fourth quarter of 2013. | |||||||||||||||||
2012 | Health and Wellness | Heritage Labs | Hooper Holmes Services | Unallocated Corporate | Total | ||||||||||||
Revenues | $ | 21,349 | $ | 13,154 | $ | 16,474 | $ | — | $ | 50,977 | |||||||
Depreciation and amortization expense | 563 | 620 | 371 | 813 | 2,367 | ||||||||||||
Operating income (loss) | 989 | 764 | (2,475 | ) | (6,315 | ) | (a) | (7,037 | ) | ||||||||
Capital expenditures | 818 | 752 | 109 | 408 | 2,087 | ||||||||||||
Segment assets | 6,261 | 4,624 | 3,320 | 22,213 | 36,418 | ||||||||||||
a) Unallocated corporate includes selling, general and administrative costs that the Company has not allocated to its segments. | |||||||||||||||||
2011 | Health and Wellness | Heritage Labs | Hooper Holmes Services | Unallocated Corporate | Total | ||||||||||||
Revenues | $ | 18,441 | $ | 13,664 | $ | 18,977 | $ | — | $ | 51,082 | |||||||
Depreciation and amortization expense | 409 | 455 | 340 | 1,110 | 2,314 | ||||||||||||
Operating income (loss) | 1,992 | 596 | (3,348 | ) | (7,011 | ) | (a) | (7,771 | ) | ||||||||
Capital expenditures | 788 | 254 | 413 | 500 | 1,955 | ||||||||||||
a) Unallocated corporate includes selling, general and administrative costs that the Company has not allocated to its segments. |
Quarterly_Financial_Data_Unaud
Quarterly Financial Data (Unaudited) | 12 Months Ended | ||||||||||||
Dec. 31, 2013 | |||||||||||||
Quarterly Financial Data [Abstract] | ' | ||||||||||||
Quarterly Financial Data | ' | ||||||||||||
Quarterly Financial Data (Unaudited) | |||||||||||||
(dollars in thousands, except per share data) | |||||||||||||
2013 Quarters | |||||||||||||
First | Second | Third (b) | Fourth | ||||||||||
Revenues | $ | 12,359 | $ | 10,841 | $ | 10,993 | $ | 14,967 | |||||
Gross profit | 3,199 | 2,552 | 1,973 | 3,818 | |||||||||
Loss from continuing operations | (2,027 | ) | (3,177 | ) | (3,564 | ) | (1,487 | ) | |||||
(Loss) income from discontinued operations | (533 | ) | (1,825 | ) | 1,850 | (512 | ) | ||||||
Net loss | (2,560 | ) | (5,002 | ) | (1,714 | ) | (1,999 | ) | |||||
Basic (loss) earnings per share (a) | |||||||||||||
Loss from continuing operations | $ | (0.03 | ) | $ | (0.05 | ) | $ | (0.05 | ) | $ | (0.02 | ) | |
(Loss) income from discontinued operations | (0.01 | ) | (0.03 | ) | 0.03 | (0.01 | ) | ||||||
Net loss | (0.04 | ) | (0.07 | ) | (0.02 | ) | (0.03 | ) | |||||
Diluted (loss) earnings per share (a) | |||||||||||||
Loss from continuing operations | $ | (0.03 | ) | $ | (0.05 | ) | $ | (0.05 | ) | $ | (0.02 | ) | |
(Loss) income from discontinued operations | (0.01 | ) | (0.03 | ) | 0.03 | (0.01 | ) | ||||||
Net loss | (0.04 | ) | (0.07 | ) | (0.02 | ) | (0.03 | ) | |||||
2012 Quarters | |||||||||||||
First | Second | Third (b) | Fourth | ||||||||||
Revenues | $ | 12,307 | $ | 11,180 | $ | 12,299 | $ | 15,191 | |||||
Gross profit | 3,316 | 2,754 | 3,282 | 3,947 | |||||||||
Loss from continuing operations | (2,086 | ) | (2,614 | ) | (1,318 | ) | (1,059 | ) | |||||
Loss from discontinued operations | (1,052 | ) | (2,916 | ) | (875 | ) | (5,678 | ) | |||||
Net loss | (3,138 | ) | (5,530 | ) | (2,193 | ) | (6,737 | ) | |||||
Basic loss per share (a) | |||||||||||||
Loss from continuing operations | $ | (0.03 | ) | $ | (0.04 | ) | $ | (0.02 | ) | $ | (0.02 | ) | |
Loss from discontinued operations | (0.02 | ) | (0.04 | ) | (0.01 | ) | (0.08 | ) | |||||
Net loss | (0.05 | ) | (0.08 | ) | (0.03 | ) | (0.10 | ) | |||||
Diluted loss per share (a) | |||||||||||||
Loss from continuing operations | $ | (0.03 | ) | $ | (0.04 | ) | $ | (0.02 | ) | $ | (0.02 | ) | |
Loss from discontinued operations | (0.02 | ) | (0.04 | ) | (0.01 | ) | (0.08 | ) | |||||
Net loss | (0.05 | ) | (0.08 | ) | (0.03 | ) | (0.10 | ) | |||||
a) Due to rounding, the sum of the quarters may not equal the full year. | |||||||||||||
(b) Adjustments to correct immaterial errors have been made to amounts previously reported in the Company’s Form 10-Q for the quarterly period ended September 30, 2013 related to errors in allocation of amounts of cost of operations and selling, general and administrative expenses between continuing operations and discontinued operations and classification of other expenses. For the three months ended September 30, 2013 and 2012 and the nine months ended September 30, 2013 and 2012, these adjustments increased cost of operations and decreased gross profit by $0.3 million, $0.3 million, $0.8 million, and $0.9 million, increased (decreased) selling, general and administrative expenses by $0.03 million, $(0.07) million, $(0.03) million and $(0.2) million, decreased other expense, net by $0.05 million, $0.06 million, $0.2 million and $0.2 million, and increased loss from continuing operations by $0.3 million, $0.1 million, $0.6 million and $0.6 million. Income from discontinued operations increased $0.3 million for the three months ended September 30, 2013 and loss from discontinued operations decreased $0.1 million, $0.6 million and $0.6 million for the three months ended September 30, 2012 and the nine months ended September 30, 2013 and 2012, respectively. |
Schedule_II_Valuation_and_Qual
Schedule II - Valuation and Qualifying Accounts | 12 Months Ended | ||||||||||||||||
Dec. 31, 2013 | |||||||||||||||||
Schedule II - Valuation and Qualifying Accounts [Abstract] | ' | ||||||||||||||||
Schedule of Valuation and Qualifying Accounts Disclosure | ' | ||||||||||||||||
Schedule II | |||||||||||||||||
Hooper Holmes, Inc | |||||||||||||||||
Valuation and Qualifying Accounts | |||||||||||||||||
For the Three Years Ended December 31, 2013 | |||||||||||||||||
(In thousands) | |||||||||||||||||
Description | Balance at Beginning of | Additions Charged to Revenues and Expenses (1) | Deductions (2) | Balance at | |||||||||||||
Period | End of | ||||||||||||||||
Period | |||||||||||||||||
Year ended December 31, 2013 | |||||||||||||||||
Reserves and allowances | |||||||||||||||||
Accounts receivable allowance | $ | 662 | $ | 1,576 | $ | (2,085 | ) | $ | 153 | ||||||||
Year ended December 31, 2012 | |||||||||||||||||
Reserves and allowances | |||||||||||||||||
Accounts receivable allowance | $ | 525 | $ | 2,359 | $ | (2,222 | ) | $ | 662 | ||||||||
Year ended December 31, 2011 | |||||||||||||||||
Reserves and allowances | |||||||||||||||||
Accounts receivable allowance | $ | 910 | $ | 2,030 | $ | (2,415 | ) | $ | 525 | ||||||||
-1 | Includes $1.6 million, $2.2 million and $0.19 million in 2013, 2012 and 2011, respectively, charged as a reduction to revenues. | ||||||||||||||||
-2 | Represents accounts receivable write-offs, net of recoveries and reserve reductions credited to revenue. |
Summary_of_Significant_Account1
Summary of Significant Accounting Policies (Policies) | 12 Months Ended |
Dec. 31, 2013 | |
Accounting Policies [Abstract] | ' |
Principles of Consolidation | ' |
The consolidated financial statements include the accounts of Hooper Holmes, Inc. and its wholly owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation. | |
Cash and Cash Equivalents | ' |
The Company considers highly liquid investments with original maturities at the date of purchase of less than 90 days to be cash equivalents. | |
Accounts Receivable | ' |
Trade accounts receivable are recorded at the invoiced amount and do not bear interest. The Company maintains allowances for doubtful accounts for (i) estimated losses resulting from the inability of our customers to make required payments and (ii) estimated amounts that customers may deduct from their remittances to the Company for billed items not in compliance with customer specifications. Allowances for uncollectible accounts are estimated based on the Company's periodic review of accounts receivable historical losses, current receivables aging and existing industry and economic data. Account balances are charged off to the allowance after all means of collections have been exhausted and potential for recovery is considered remote. Customer billing adjustments are recorded against revenue whereas adjustments for bad debts are recorded within selling, general and administrative expenses. Accounts receivable are net of an allowance for doubtful accounts and pricing adjustments | |
Inventories | ' |
Inventories, which consist of finished goods and component inventory, are stated at the lower of average cost or market. | |
Property, Plant and Equipment | ' |
Property, plant and equipment are stated at cost less accumulated depreciation. Depreciation is computed using the straight-line method over the assets’ estimated useful lives. Leasehold improvements are amortized over the shorter of the estimated useful life of the improvement or the remaining lease term. The cost of maintenance and repairs is charged to operations as incurred. | |
Internal use software and website development costs are capitalized and included in property, plant and equipment in the consolidated balance sheet. These assets are depreciated over the estimated useful life of the asset using the straight-line method. Subsequent modifications or upgrades to internal use software are capitalized only to the extent that additional functionality is provided. | |
Long-Lived Assets | ' |
Long-lived assets, including intangible assets with determinable useful lives, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of the assets to the future undiscounted net cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets and is charged to earnings. Assets to be disposed of are reported at the lower of the carrying amount or fair value less the costs to sell. Intangible assets with determinable useful lives are amortized on a straight line basis over their respective estimated useful lives and were fully amortized as of December 31, 2012. | |
Deferred Rent | ' |
The Company accounts for scheduled rent increases contained in its leases on a straight-line basis over the term of the lease. | |
Advertising | ' |
Costs related to space in publications are expensed as incurred. | |
Revenue Recognition | ' |
Revenue is recognized for Health and Wellness services when the wellness screening is completed and the results are delivered to customers. Revenues generated from medical record collection, laboratory testing, fingerstick test kits and other services are recognized when the related service is completed and the results are delivered to our customers. Revenue for kit assembly in Heritage Labs is recorded upon shipment to the customers. In all cases, there must be evidence of an agreement with the customer, the sales price must be fixed or determinable, delivery of services must occur and the ability to collect must be reasonably assured. | |
Sales tax collected from customers and remitted to governmental authorities is accounted for on a net basis and therefore is excluded from revenues in the consolidated statements of operations. | |
Share-based Compensation | ' |
The Company recognizes share-based compensation cost on a straight-line basis over the vesting period. Compensation cost is measured at the grant date based on the fair value of the award. | |
The fair value of each stock option granted during the year was estimated on the date of grant using the Black-Scholes option pricing model | |
The Company’s initial accruals for share-based compensation expense are based on the estimated number of instruments for which the requisite service is expected to be rendered. Therefore, the Company is required to incorporate the probability of pre-vesting forfeitures in determining the number of options and restricted stock that are estimated to vest. The forfeiture rate is based on historical forfeiture experience. The Company monitors employee termination patterns to estimate forfeiture rates. | |
Income Taxes | ' |
Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. A valuation allowance is provided when it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income and the reversal of deferred tax liabilities during the period in which related temporary differences become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income and tax planning strategies in making this assessment. | |
Income Tax Uncertainties | ' |
The Company recognizes the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the financial statements from such a position are measured based on the largest benefit that has a greater than fifty percent likelihood of being realized upon settlement with the tax authorities. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs. The Company records interest related to unrecognized tax benefits in interest expense and penalties in income tax expense. | |
(Loss) Earnings per Common Share | ' |
Basic (loss) earnings per share equals net (loss) income divided by the weighted average common shares outstanding during the period. Diluted (loss) earnings per share equals net (loss) income divided by the sum of the weighted average common shares outstanding during the period plus dilutive common stock equivalents. | |
Use of Estimates | ' |
The preparation of the accompanying consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions about future events. These estimates and the underlying assumptions affect the amounts of assets and liabilities reported, disclosures about contingent assets and liabilities, and reported amounts of revenues and expenses. Such estimates include the valuation of accounts receivable as well as the Holdback Amount, property, plant and equipment, deferred tax assets and the assessment of contingencies, among others. These estimates and assumptions are based on the Company’s best estimates and judgment. The Company evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, which the Company believes to be reasonable under the circumstances. The Company adjusts such estimates and assumptions when facts and circumstances dictate. As future events and their effects cannot be determined with precision, actual results could differ significantly from these estimates. Changes in those estimates will be reflected in the consolidated financial statements in future periods. | |
Impairment of Long-Lived Assets | ' |
The Company evaluates the recovery of its long-lived assets when events or changes in circumstances occur that indicate that the carrying value of assets may not be recoverable. |
Summary_of_Significant_Account2
Summary of Significant Accounting Policies (Tables) | 12 Months Ended | |||||||||||||
Dec. 31, 2013 | ||||||||||||||
Accounting Policies [Abstract] | ' | |||||||||||||
Schedule of Earnings Per Share, Basic and Diluted | ' | |||||||||||||
The computation of basic and diluted (loss) earnings per share for the three years ended December 31, 2013 is included in the table below. The calculation of (loss) earnings per common share on a basic and diluted basis was the same as there was no impact of dilutive common stock equivalents for all periods presented. | ||||||||||||||
For the Years Ended December 31, | ||||||||||||||
2013 | 2012 | 2011 | ||||||||||||
(Loss) earnings - basic and diluted: | ||||||||||||||
Loss from continuing operations | $ | (10,255 | ) | $ | (7,077 | ) | $ | (7,802 | ) | |||||
(Loss) income from discontinued operations | (1,020 | ) | (10,521 | ) | 4,278 | |||||||||
Net loss | $ | (11,275 | ) | $ | (17,598 | ) | $ | (3,524 | ) | |||||
Weighted average shares outstanding: | ||||||||||||||
Weighted average shares outstanding - basic | 69,965,814 | 69,743,897 | 69,628,135 | |||||||||||
Effect of dilutive common stock options | ||||||||||||||
and restricted stock | — | — | — | |||||||||||
Weighted average shares outstanding - diluted | 69,965,814 | 69,743,897 | 69,628,135 | |||||||||||
Basic and diluted (loss) earnings per share: | ||||||||||||||
Continuing operations | $ | (0.15 | ) | $ | (0.10 | ) | $ | (0.11 | ) | |||||
Discontinued Operations | $ | (0.01 | ) | $ | (0.15 | ) | $ | 0.06 | ||||||
Net loss | $ | (0.16 | ) | $ | (0.25 | ) | $ | (0.05 | ) |
ShareBased_Compensation_Tables
Share-Based Compensation (Tables) | 12 Months Ended | ||||||||||
Dec. 31, 2013 | |||||||||||
Share-based Compensation [Abstract] | ' | ||||||||||
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions | ' | ||||||||||
The fair value of each stock option granted during the year was estimated on the date of grant using the Black-Scholes option pricing model with the following weighted average assumptions: | |||||||||||
2013 | 2012 | 2011 | |||||||||
Expected life (years) | 5.4 | 5.5 | 5.5 | ||||||||
Expected volatility | 89.6 | % | 92.4 | % | 92.6 | % | |||||
Expected dividend yield | — | — | — | ||||||||
Risk-free interest rate | 1.5 | % | 0.7 | % | 1.6 | % | |||||
Weighted average fair value of options granted during the year | $0.34 | $0.47 | $0.69 | ||||||||
Schedule of Share-based Compensation, Stock Options, Activity | ' | ||||||||||
The following table summarizes stock option activity for the year ended December 31, 2013: | |||||||||||
Weighted | |||||||||||
Weighted Average | Average Remaining | Aggregate Intrinsic | |||||||||
Number of Shares | Exercise Price Per Share | Contractual Life (years) | Value (in thousands) | ||||||||
Outstanding at December 31, 2012 | 6,429,250 | $1.28 | |||||||||
Granted | 2,325,000 | $0.47 | |||||||||
Exercised | (182,930 | ) | 0.39 | ||||||||
Expired | (2,514,070 | ) | $1.96 | ||||||||
Forfeited | (1,906,700 | ) | $0.54 | ||||||||
Outstanding at December 31, 2013 | 4,150,550 | $0.75 | 8.3 | $2 | |||||||
Exercisable at December 31, 2013 | 1,907,350 | $1.04 | 6.8 | $2 | |||||||
Discontinued_Operations_Tables
Discontinued Operations (Tables) | 12 Months Ended | |||||||||
Dec. 31, 2013 | ||||||||||
Discontinued Operations and Disposal Groups [Abstract] | ' | |||||||||
Schedule of Disposal Groups, Including Discontinued Operations, Income Statement, Balance Sheet and Additional Disclosures | ' | |||||||||
The following summarizes the operating results of Portamedic and the gain on sale of Portamedic which are reported in discontinued operations in the accompanying consolidated statements of operations for the years ended December 31, 2013, 2012 and 2011: | ||||||||||
2013 | 2012 | 2011 | ||||||||
Revenue | $ | 66,467 | $ | 100,400 | $ | 111,417 | ||||
(Loss) income from discontinued operations | $ | (4,450 | ) | $ | (10,586 | ) | $ | 4,216 | ||
Gain on sale of Portamedic | $ | 3,355 | $ | — | $ | — | ||||
Income taxes relating to the operations of Portamedic were less than $0.1 million for each period | ||||||||||
presented and there were no income taxes on the gain on the sale due to the availability of net operating loss carry forwards with full valuation allowance. | ||||||||||
The assets and liabilities of the discontinued Portamedic operations are presented separately under the captions “Assets held for sale” and “Liabilities held for sale,” respectively, in the accompanying consolidated balance sheet as of December 31, 2012 and consist of the following: | ||||||||||
(in thousands) | 31-Dec-12 | |||||||||
Assets held for sale: | ||||||||||
Inventories | $ | 941 | ||||||||
Other current assets | 400 | |||||||||
Property, plant and equipment, net | 2,080 | |||||||||
Other assets | 225 | |||||||||
Total assets | $ | 3,646 | ||||||||
Liabilities held for sale: | ||||||||||
Deferred rent | 104 | |||||||||
Capital leases | 116 | |||||||||
Total liabilities | $ | 220 | ||||||||
Restructuring_Charges_Tables
Restructuring Charges (Tables) | 12 Months Ended | |||||||||||||||
Dec. 31, 2013 | ||||||||||||||||
Restructuring Charges [Abstract] | ' | |||||||||||||||
Schedule of Restructuring and Related Costs | ' | |||||||||||||||
Following is a summary of the restructuring charges for the year ended December 31, 2013 | ||||||||||||||||
As of | As of | |||||||||||||||
(In millions) | 31-Dec-12 | Charges | Payments | 31-Dec-13 | ||||||||||||
Severance | $ | — | $ | 1.3 | $ | (0.8 | ) | $ | 0.5 | |||||||
Lease closure obligation | 0.7 | 0.6 | (0.9 | ) | 0.4 | |||||||||||
Total | $ | 0.7 | $ | 1.9 | $ | (1.7 | ) | $ | 0.9 | |||||||
Property_Plant_and_Equipment_T
Property, Plant and Equipment (Tables) | 12 Months Ended | ||||||||||
Dec. 31, 2013 | |||||||||||
Property, Plant and Equipment [Abstract] | ' | ||||||||||
Property, Plant and Equipment | ' | ||||||||||
Property, plant and equipment, at cost, consists of the following: | |||||||||||
Estimated | |||||||||||
December 31, | Useful Life | ||||||||||
2013 | 2012 | In Years | |||||||||
Land and improvements | $ | — | $ | 639 | |||||||
Building and leasehold improvements | 1,864 | 6,935 | 3 – 45 | ||||||||
Furniture, fixtures and equipment | 9,542 | 9,650 | 2 – 10 | ||||||||
Software | 4,612 | 3,605 | 1 – 7 | ||||||||
16,018 | 20,829 | ||||||||||
Less accumulated depreciation and amortization | 12,257 | 15,195 | |||||||||
Total | $ | 3,761 | $ | 5,634 | |||||||
Accrued_Expenses_Tables
Accrued Expenses (Tables) | 12 Months Ended | ||||||||
Dec. 31, 2013 | |||||||||
Payables and Accruals [Abstract] | ' | ||||||||
Accrued Liabilities | ' | ||||||||
Accrued expenses consisted of the following: | |||||||||
December 31, | |||||||||
2013 | 2012 | ||||||||
Accrued wages | $ | 332 | $ | 1,292 | |||||
Reserve for unclaimed property | 910 | 752 | |||||||
Restructure reserves | 870 | 444 | |||||||
Other accrued expenses | 1,924 | 1,951 | |||||||
$ | 4,036 | $ | 4,439 | ||||||
Commitments_and_Contingencies_
Commitments and Contingencies (Tables) | 12 Months Ended | ||||
Dec. 31, 2013 | |||||
Commitments and Contingencies Disclosure [Abstract] | ' | ||||
Schedule of Future Payments for Operating and Capital Leases | ' | ||||
The table below presents future minimum lease payments for operating leases (with initial or remaining terms in excess of one year) as of December 31, 2013 and includes leases from both continuing and discontinued operations, as described above. | |||||
Year ending December 31, | Operating | ||||
Leases | |||||
2014 | $ | 2,535 | |||
2015 | 1,806 | ||||
2016 | 1,524 | ||||
2017 | 1,378 | ||||
2018 | 1,104 | ||||
Thereafter | — | ||||
Total minimum lease payments | $ | 8,347 | |||
Income_Taxes_Tables
Income Taxes (Tables) | 12 Months Ended | ||||||||||||
Dec. 31, 2013 | |||||||||||||
Income Tax Disclosure [Abstract] | ' | ||||||||||||
Schedule of Components of Income Tax Expense | ' | ||||||||||||
The components of the income tax provision are as follows: | |||||||||||||
2013 | 2012 | 2011 | |||||||||||
Federal - current | $ | — | $ | — | $ | — | |||||||
State and local - current | 19 | 23 | 36 | ||||||||||
$ | 19 | $ | 23 | $ | 36 | ||||||||
Schedule of Effective Income Tax Rate Reconciliation | ' | ||||||||||||
The following reconciles the “statutory” federal income tax rate to the effective income tax rate: | |||||||||||||
2013 | 2012 | 2011 | |||||||||||
Computed "expected" income tax benefit | (35 | )% | (35 | )% | (35 | )% | |||||||
Reduction (increase) in income tax benefit and increase (reduction) in income tax expense resulting from: | |||||||||||||
State tax, net of federal benefit | — | — | — | ||||||||||
Change in federal valuation allowance | 35 | 35 | 35 | ||||||||||
Other | — | — | — | ||||||||||
Effective income tax rate | — | % | — | % | — | % | |||||||
Schedule of Deferred Tax Assets and Liabilities | ' | ||||||||||||
The tax effects of temporary differences that give rise to the deferred tax assets and liabilities at December 31, 2013 and 2012 are as follows: | |||||||||||||
2013 | 2012 | ||||||||||||
Deferred tax assets: | |||||||||||||
Receivable allowance | $ | 59 | $ | 259 | |||||||||
Goodwill | 4,238 | 6,459 | |||||||||||
Restructuring accrual | 370 | 215 | |||||||||||
Impairment and accumulated depreciation | — | 675 | |||||||||||
Intangible assets | 845 | 1,309 | |||||||||||
Compensation expense | 1,518 | 1,399 | |||||||||||
Federal net operating loss carryforward | 48,990 | 40,773 | |||||||||||
State net operating loss carryforward | 5,756 | 5,109 | |||||||||||
AMT credit carry forward | — | 157 | |||||||||||
Accrued expenses | 25 | 65 | |||||||||||
Deferred rent | 131 | 177 | |||||||||||
Other | 167 | 182 | |||||||||||
Gross deferred tax assets | $ | 62,099 | $ | 56,779 | |||||||||
Valuation allowance | (61,500 | ) | (56,779 | ) | |||||||||
$ | 599 | $ | — | ||||||||||
Deferred tax liabilities: | |||||||||||||
Impairment and accumulated depreciation | (599 | ) | — | ||||||||||
Gross deferred tax liabilities | (599 | ) | — | ||||||||||
Net deferred tax assets | $ | — | $ | — | |||||||||
Segments_Tables
Segments (Tables) | 12 Months Ended | ||||||||||||||||
Dec. 31, 2013 | |||||||||||||||||
Segment Reporting [Abstract] | ' | ||||||||||||||||
Revenue by Segment | ' | ||||||||||||||||
The table presented below provides disclosures by segment for the years ended December 31, 2013, 2012 and 2011. Intercompany revenue for the years ended December 31, 2013, 2012 and 2011 was $1.1 million, $2.1 million and $2.0 million, representing Heritage Lab revenue for kit sales to the discontinued Portamedic operations at arms' length sales prices. Heritage Lab also performs services to Health and Wellness. These services are recorded at Heritage Labs' cost directly within the Health and Wellness segment, and thus, no intercompany elimination is required. | |||||||||||||||||
2013 | Health and Wellness | Heritage Labs | Hooper Holmes Services | Unallocated Corporate | Total | ||||||||||||
Revenues | $ | 23,149 | $ | 11,390 | $ | 14,621 | $ | — | $ | 49,160 | |||||||
Depreciation and amortization expense | 655 | 423 | 260 | 508 | 1,846 | ||||||||||||
Operating income (loss) | 5 | 619 | (1,716 | ) | (8,664 | ) | (a) | (9,756 | ) | ||||||||
Capital expenditures | 347 | 56 | — | 122 | 525 | ||||||||||||
Segment assets | 6,937 | 4,094 | 1,994 | 8,621 | 21,646 | ||||||||||||
a) Unallocated corporate includes selling, general and administrative costs that the Company has not allocated to its segments. The method of allocating selling, general and administrative costs to Health and Wellness, Heritage Labs and Hooper Holmes Services did not change subsequent to the sale of Portamedic. Allocations that would have been made to Portamedic in the fourth quarter of 2013 if it had still been owned by the Company were made using previously budgeted amounts, which resulted in higher unallocated amounts in corporate during the fourth quarter of 2013. | |||||||||||||||||
2012 | Health and Wellness | Heritage Labs | Hooper Holmes Services | Unallocated Corporate | Total | ||||||||||||
Revenues | $ | 21,349 | $ | 13,154 | $ | 16,474 | $ | — | $ | 50,977 | |||||||
Depreciation and amortization expense | 563 | 620 | 371 | 813 | 2,367 | ||||||||||||
Operating income (loss) | 989 | 764 | (2,475 | ) | (6,315 | ) | (a) | (7,037 | ) | ||||||||
Capital expenditures | 818 | 752 | 109 | 408 | 2,087 | ||||||||||||
Segment assets | 6,261 | 4,624 | 3,320 | 22,213 | 36,418 | ||||||||||||
a) Unallocated corporate includes selling, general and administrative costs that the Company has not allocated to its segments. | |||||||||||||||||
2011 | Health and Wellness | Heritage Labs | Hooper Holmes Services | Unallocated Corporate | Total | ||||||||||||
Revenues | $ | 18,441 | $ | 13,664 | $ | 18,977 | $ | — | $ | 51,082 | |||||||
Depreciation and amortization expense | 409 | 455 | 340 | 1,110 | 2,314 | ||||||||||||
Operating income (loss) | 1,992 | 596 | (3,348 | ) | (7,011 | ) | (a) | (7,771 | ) | ||||||||
Capital expenditures | 788 | 254 | 413 | 500 | 1,955 | ||||||||||||
a) Unallocated corporate includes selling, general and administrative costs that the Company has not allocated to its segments. |
Quarterly_Financial_Data_Unaud1
Quarterly Financial Data (Unaudited) (Tables) | 12 Months Ended | ||||||||||||
Dec. 31, 2013 | |||||||||||||
Quarterly Financial Data [Abstract] | ' | ||||||||||||
Schedule of Quarterly Financial Information [Table Text Block] | ' | ||||||||||||
Quarterly Financial Data (Unaudited) | |||||||||||||
(dollars in thousands, except per share data) | |||||||||||||
2013 Quarters | |||||||||||||
First | Second | Third (b) | Fourth | ||||||||||
Revenues | $ | 12,359 | $ | 10,841 | $ | 10,993 | $ | 14,967 | |||||
Gross profit | 3,199 | 2,552 | 1,973 | 3,818 | |||||||||
Loss from continuing operations | (2,027 | ) | (3,177 | ) | (3,564 | ) | (1,487 | ) | |||||
(Loss) income from discontinued operations | (533 | ) | (1,825 | ) | 1,850 | (512 | ) | ||||||
Net loss | (2,560 | ) | (5,002 | ) | (1,714 | ) | (1,999 | ) | |||||
Basic (loss) earnings per share (a) | |||||||||||||
Loss from continuing operations | $ | (0.03 | ) | $ | (0.05 | ) | $ | (0.05 | ) | $ | (0.02 | ) | |
(Loss) income from discontinued operations | (0.01 | ) | (0.03 | ) | 0.03 | (0.01 | ) | ||||||
Net loss | (0.04 | ) | (0.07 | ) | (0.02 | ) | (0.03 | ) | |||||
Diluted (loss) earnings per share (a) | |||||||||||||
Loss from continuing operations | $ | (0.03 | ) | $ | (0.05 | ) | $ | (0.05 | ) | $ | (0.02 | ) | |
(Loss) income from discontinued operations | (0.01 | ) | (0.03 | ) | 0.03 | (0.01 | ) | ||||||
Net loss | (0.04 | ) | (0.07 | ) | (0.02 | ) | (0.03 | ) | |||||
2012 Quarters | |||||||||||||
First | Second | Third (b) | Fourth | ||||||||||
Revenues | $ | 12,307 | $ | 11,180 | $ | 12,299 | $ | 15,191 | |||||
Gross profit | 3,316 | 2,754 | 3,282 | 3,947 | |||||||||
Loss from continuing operations | (2,086 | ) | (2,614 | ) | (1,318 | ) | (1,059 | ) | |||||
Loss from discontinued operations | (1,052 | ) | (2,916 | ) | (875 | ) | (5,678 | ) | |||||
Net loss | (3,138 | ) | (5,530 | ) | (2,193 | ) | (6,737 | ) | |||||
Basic loss per share (a) | |||||||||||||
Loss from continuing operations | $ | (0.03 | ) | $ | (0.04 | ) | $ | (0.02 | ) | $ | (0.02 | ) | |
Loss from discontinued operations | (0.02 | ) | (0.04 | ) | (0.01 | ) | (0.08 | ) | |||||
Net loss | (0.05 | ) | (0.08 | ) | (0.03 | ) | (0.10 | ) | |||||
Diluted loss per share (a) | |||||||||||||
Loss from continuing operations | $ | (0.03 | ) | $ | (0.04 | ) | $ | (0.02 | ) | $ | (0.02 | ) | |
Loss from discontinued operations | (0.02 | ) | (0.04 | ) | (0.01 | ) | (0.08 | ) | |||||
Net loss | (0.05 | ) | (0.08 | ) | (0.03 | ) | (0.10 | ) | |||||
a) Due to rounding, the sum of the quarters may not equal the full year. |
Summary_of_Significant_Account3
Summary of Significant Accounting Policies Accounts Receivable (Details) (USD $) | Dec. 31, 2013 | Dec. 31, 2012 |
In Thousands, unless otherwise specified | ||
Accounting Policies [Abstract] | ' | ' |
Allowance for doubtful accounts | $153 | $662 |
Summary_of_Significant_Account4
Summary of Significant Accounting Policies Inventories (Details) (USD $) | Dec. 31, 2013 | Dec. 31, 2012 |
In Millions, unless otherwise specified | ||
Accounting Policies [Abstract] | ' | ' |
Inventory, finished goods | $0.40 | $0.40 |
Inventory, components | $1 | $0.90 |
Summary_of_Significant_Account5
Summary of Significant Accounting Policies Long-Lived Assets (Details) (USD $) | 12 Months Ended | |
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 |
Accounting Policies [Abstract] | ' | ' |
Amortization expense | $200 | $200 |
Summary_of_Significant_Account6
Summary of Significant Accounting Policies Advertising (Details) (USD $) | 12 Months Ended | ||
In Millions, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
Accounting Policies [Abstract] | ' | ' | ' |
Advertising expense | $0.10 | $0.20 | $0.20 |
Summary_of_Significant_Account7
Summary of Significant Accounting Policies (Loss) Earnings per Common Share (Details) (USD $) | 3 Months Ended | 12 Months Ended | |||||||||
In Thousands, except Share data, unless otherwise specified | Dec. 31, 2013 | Sep. 30, 2013 | Jun. 30, 2013 | Mar. 31, 2013 | Dec. 31, 2012 | Sep. 30, 2012 | Jun. 30, 2012 | Mar. 31, 2012 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
(Loss) earnings - basic and diluted: | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
(Loss) income from continuing operations | ($1,487) | ($3,564) | ($3,177) | ($2,027) | ($1,059) | ($1,318) | ($2,614) | ($2,086) | ($10,255) | ($7,077) | ($7,802) |
(Loss) income from discontinued operations | ' | ' | ' | ' | ' | ' | ' | ' | -1,020 | -10,521 | 4,278 |
Net loss | ($1,999) | ($1,714) | ($5,002) | ($2,560) | ($6,737) | ($2,193) | ($5,530) | ($3,138) | ($11,275) | ($17,598) | ($3,524) |
Weighted average shares outstanding: | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Weighted average number of shares - Basic | ' | ' | ' | ' | ' | ' | ' | ' | 69,965,814 | 69,743,897 | 69,628,135 |
Effect of dilutive common stock options and restricted stock | ' | ' | ' | ' | ' | ' | ' | ' | 0 | 0 | 0 |
Weighted average number of shares - Diluted | ' | ' | ' | ' | ' | ' | ' | ' | 69,965,814 | 69,743,897 | 69,628,135 |
Basic and diluted (loss) earnings per share: | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Continuing operations (usd per share) | ' | ' | ' | ' | ' | ' | ' | ' | ($0.15) | ($0.10) | ($0.11) |
Discontinued operations (usd per share) | ' | ' | ' | ' | ' | ' | ' | ' | ($0.01) | ($0.15) | $0.06 |
Net loss (usd per share) | ' | ' | ' | ' | ' | ' | ' | ' | ($0.16) | ($0.25) | ($0.05) |
Antidilutive options excluded from computation of (loss) earnings per share | ' | ' | ' | ' | ' | ' | ' | ' | 3,455,000 | 5,171,000 | 4,028,000 |
Summary_of_Significant_Account8
Summary of Significant Accounting Policies Concentration of Credit Risk (Details) (Customer Concentration Risk [Member]) | 12 Months Ended | ||||
Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | Dec. 31, 2013 | Dec. 31, 2012 | |
Accounts Receivable [Member] | Accounts Receivable [Member] | Sales [Member] | Sales [Member] | Sales [Member] | |
customer | customer | customer | Health & Wellness [Member] | Health & Wellness [Member] | |
customer | customer | ||||
Concentration Risk [Line Items] | ' | ' | ' | ' | ' |
Concentration risk, percentage | 42.00% | ' | ' | ' | ' |
Number of major customers | 3 | 0 | 0 | 1 | 2 |
Liquidity_Details
Liquidity (Details) (USD $) | 3 Months Ended | 12 Months Ended | 0 Months Ended | 12 Months Ended | 3 Months Ended | 12 Months Ended | ||||||||||||
Dec. 31, 2013 | Sep. 30, 2013 | Jun. 30, 2013 | Mar. 31, 2013 | Dec. 31, 2012 | Sep. 30, 2012 | Jun. 30, 2012 | Mar. 31, 2012 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | Dec. 31, 2010 | Feb. 21, 2014 | Sep. 30, 2013 | Dec. 31, 2013 | Mar. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2013 | |
Subsequent Event [Member] | Portamedic Service Line [Member] | Portamedic Service Line [Member] | Portamedic Service Line [Member] | Minimum [Member] | Maximum [Member] | |||||||||||||
holdback_component | Subsequent Event [Member] | Portamedic Service Line [Member] | Portamedic Service Line [Member] | |||||||||||||||
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Cash and cash equivalents | $3,970,000 | ' | ' | ' | $8,319,000 | ' | ' | ' | $3,970,000 | $8,319,000 | $16,917,000 | $21,391,000 | ' | ' | ' | ' | ' | ' |
Working capital | ' | ' | ' | ' | ' | ' | ' | ' | 8,600,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' |
(Loss) income from continuing operations | -1,487,000 | -3,564,000 | -3,177,000 | -2,027,000 | -1,059,000 | -1,318,000 | -2,614,000 | -2,086,000 | -10,255,000 | -7,077,000 | -7,802,000 | ' | ' | ' | ' | ' | ' | ' |
Restructuring charges, continuing operations | ' | ' | ' | ' | ' | ' | ' | ' | 813,000 | 566,000 | 34,000 | ' | ' | ' | ' | ' | ' | ' |
Net cash (used in) provided by operating activities of continuing operations | ' | ' | ' | ' | ' | ' | ' | ' | -7,029,000 | -4,177,000 | 786,000 | ' | ' | ' | ' | ' | ' | ' |
Holdback Amount | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 2,000,000 | ' | ' | ' | ' |
Number of holdback components | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 2 | ' | ' | ' | ' |
Holdback amount, component one | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 1,000,000 | ' | ' | ' | ' |
Holdback amount, component two | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 1,000,000 | ' | ' | ' | ' |
Amount of Holdback received | ' | ' | ' | ' | ' | ' | ' | ' | 6,053,000 | 0 | 0 | ' | ' | 8,100,000 | 6,100,000 | 800,000 | ' | ' |
Term of loan and security agreement | ' | ' | ' | ' | ' | ' | ' | ' | '3 years | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Maximum borrowing capacity under Loan and Security Agreement | 10,000,000 | ' | ' | ' | ' | ' | ' | ' | 10,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Loan maximum defined, based on eligible receivables | 85.00% | ' | ' | ' | ' | ' | ' | ' | 85.00% | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Remaining borrowing capacity under Loan and Security Agreement | 10,000,000 | ' | ' | ' | ' | ' | ' | ' | 10,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Reserve on eligible borrowings | 1,500,000 | ' | ' | ' | ' | ' | ' | ' | 1,500,000 | ' | ' | ' | 500,000 | ' | ' | ' | ' | ' |
Additional borrowing availability under Loan and Security Agreement | 2,000,000 | ' | ' | ' | ' | ' | ' | ' | 2,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Borrowings outstanding under Loan and Security Agreement | 0 | ' | ' | ' | ' | ' | ' | ' | 0 | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Eligible Receivables Generated, Percent | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 60.00% | 75.00% |
Selling, general and administrative expenses | ' | ' | ' | ' | ' | ' | ' | ' | $20,273,000 | $19,543,000 | $21,293,000 | ' | ' | ' | $10,000,000 | ' | ' | ' |
Impairment_of_Longlived_Assets1
Impairment of Long-lived Assets (Details) (USD $) | 12 Months Ended | ||
Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | |
Impairment of Long-Lived Assets [Line Items] | ' | ' | ' |
Impairment | $212,000 | $227,000 | $0 |
Impairment, discontinued operations | 200,000 | 5,100,000 | 200,000 |
Financial System Software [Member] | ' | ' | ' |
Impairment of Long-Lived Assets [Line Items] | ' | ' | ' |
Impairment | $200,000 | ' | ' |
ShareBased_Compensation_Plan_I
Share-Based Compensation Plan Information (Details) (USD $) | 12 Months Ended | 9 Months Ended | 12 Months Ended | 12 Months Ended | 1 Months Ended | 1 Months Ended | 1 Months Ended | 1 Months Ended | 1 Months Ended | 1 Months Ended | 3 Months Ended | |||||||||||||||||||
Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | Sep. 30, 2013 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | Sep. 30, 2013 | Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2013 | Jul. 31, 2009 | Dec. 31, 2013 | Dec. 31, 2010 | Dec. 31, 2013 | Jul. 31, 2012 | Dec. 31, 2013 | Sep. 30, 2013 | Dec. 31, 2013 | Jul. 31, 2011 | Dec. 31, 2013 | Dec. 31, 2013 | Jul. 29, 2011 | Dec. 31, 2013 | Sep. 30, 2013 | Dec. 31, 2013 | |
2008 Plan [Member] | 2008 Plan [Member] | 2008 Plan [Member] | 2008 Plan [Member] | 2011 Plan [Member] | 2011 Plan [Member] | 2011 Plan [Member] | Amended and Restated 2011 Plan [Member] | 1997 Plan [Member] | 1999 Plan [Member] | 2002 Plan [Member] | Restricted Stock [Member] | July 2009 Non-vested Stock Award [Member] | July 2009 Non-vested Stock Award [Member] | December 2010 Stock Option Award [Member] | December 2010 Stock Option Award [Member] | July 2012 Stock Option Award [Member] | July 2012 Stock Option Award [Member] | September 2013 Stock Option Award [Member] | September 2013 Stock Option Award [Member] | July 2011 Stock Option Award [Member] | July 2011 Stock Option Award [Member] | All Other Stock Option Awards [Member] | July 2011 Non-vested Stock Award [Member] | July 2011 Non-vested Stock Award [Member] | Chief Executive Officer [Member] | Chief Executive Officer [Member] | ||||
2008 Plan [Member] | 2011 Plan [Member] | 2011 Plan [Member] | ||||||||||||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Number of shares authorized under the Plan | ' | ' | ' | ' | 5,000,000 | ' | ' | 1,500,000 | ' | ' | 3,500,000 | 2,400,000 | 2,000,000 | 3,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Options granted in the period | 2,325,000 | ' | ' | ' | 325,000 | 900,000 | 905,000 | 2,000,000 | 1,225,000 | 75,000 | ' | ' | ' | ' | ' | ' | ' | 500,000 | ' | 700,350 | ' | 325,000 | ' | 132,700 | ' | ' | ' | ' | 2,000,000 | ' |
Granted | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 205,532 | 500,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 305,000 | ' | ' | ' |
Discretionary bonus | ' | ' | ' | $100,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Remaining shares available for grant under the Plan | ' | ' | ' | ' | 2,936,850 | ' | ' | 1,375,250 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Contractual life of stock options and other awards under share-based compensation plans | ' | ' | ' | ' | '10 years | ' | ' | '10 years | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Option Vesting Schedule [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Vesting percentage, year one | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 25.00% |
Vesting percentage, year two | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 25.00% | ' | 50.00% | ' | 33.00% | ' | 33.00% | ' | 33.00% | 25.00% | ' | 33.00% | ' | 25.00% |
Vesting percentage, year three | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 25.00% | ' | ' | ' | 34.00% | ' | 34.00% | ' | 34.00% | 25.00% | ' | 34.00% | ' | 25.00% |
Vesting percentage, year four | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 25.00% | ' | ' | ' | ' | ' | ' | ' | ' | 25.00% | ' | ' | ' | ' |
Vesting percentage, year five | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 25.00% | ' | ' | ' | ' | ' | ' | ' | ' | 25.00% | ' | ' | ' | ' |
Black-Scholes Assumptions [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Expected life (years) | '5 years 4 months 24 days | '5 years 6 months | '5 years 6 months | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Expected volatility | 89.60% | 92.40% | 92.60% | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Expected dividend yield | $0 | $0 | $0 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Risk-free interest rate | 1.50% | 0.70% | 1.60% | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Weighted average fair value of options granted during the year | $0.34 | $0.47 | $0.69 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Options exercised in period | 182,930 | 0 | 0 | ' | 173,050 | ' | ' | 9,880 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Share-based compensation expense | $643,000 | $710,000 | $647,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
ShareBased_Compensation_Option
Share-Based Compensation Option Roll-Forward (Details) (USD $) | 12 Months Ended | ||
In Thousands, except Share data, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
Stock Option Activity [Roll Forward] | ' | ' | ' |
Outstanding balance (options) at December 31, 2012 | 6,429,250 | ' | ' |
Granted (options) | 2,325,000 | ' | ' |
Options exercised in period | -182,930 | 0 | 0 |
Expired (options) | -2,514,070 | ' | ' |
Forfeited (options) | -1,906,700 | ' | ' |
Outstanding balance (options) at December 31, 2013 | 4,150,550 | 6,429,250 | ' |
Outstanding balance (weighted average exercise price) at December 31, 2012 | $1.28 | ' | ' |
Granted (weighted average exercise price) | $0.47 | ' | ' |
Exercised (weighted average exercise price) | $0.39 | ' | ' |
Expired (weighted average exercise price) | $1.96 | ' | ' |
Forfeited (weighted average exercise price) | $0.54 | ' | ' |
Outstanding balance (weighted average exercise price) at December 31, 2013 | $0.75 | $1.28 | ' |
Weighted average remaining contractual life, options outstanding | '8 years 3 months 7 days | ' | ' |
Aggregate Intrinsic Value (in thousands), options outstanding | $2 | ' | ' |
Number of options exercisable at December 31, 2013 | 1,907,350 | ' | ' |
Exercisable (weighted average exercise price) | $1.04 | ' | ' |
Weighted average remaining contractual life, options exercisable | '6 years 9 months 22 days | ' | ' |
Aggregate intrinsic value (in thousands), options exercisable | $2 | ' | ' |
ShareBased_Compensation_Award_
Share-Based Compensation Award Activity (Details) (USD $) | 12 Months Ended | 12 Months Ended | 1 Months Ended | 54 Months Ended | 1 Months Ended | 54 Months Ended | 12 Months Ended | 12 Months Ended | 12 Months Ended | 1 Months Ended | 12 Months Ended | ||||||||||||||||||||
Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | Jun. 01, 2012 | Feb. 29, 2012 | Jun. 01, 2011 | Feb. 28, 2011 | Jun. 01, 2010 | Feb. 28, 2010 | Dec. 31, 2013 | Dec. 31, 2013 | Jul. 31, 2009 | Dec. 31, 2013 | Jul. 29, 2011 | Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | Dec. 31, 2013 | Dec. 31, 2010 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | |
December 2010 Stock Option Award [Member] | Employee Stock Option [Member] | July 2009 Non-vested Stock Award [Member] | July 2009 Non-vested Stock Award [Member] | July 2011 Non-vested Stock Award [Member] | July 2011 Non-vested Stock Award [Member] | Non-Vested Stock Award [Member] | July 2011 Stock Option Award [Member] | July 2012 Stock Option Award [Member] | September 2013 Stock Option Award [Member] | All Other Stock Option Awards [Member] | 2008 Plan [Member] | 2011 Plan [Member] | Employee non-vested stock plan [Member] | Director stock plan [Member] | Director stock plan [Member] | Director stock plan [Member] | Chief Executive Officer [Member] | Former Executive Officers [Member] | Continuing Operations [Member] | Continuing Operations [Member] | Continuing Operations [Member] | ||||||||||
2011 Plan [Member] | |||||||||||||||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Options exercised in period | 182,930 | 0 | 0 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 173,050 | 9,880 | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Options exercised in period (weighted average exercise price) | $0.39 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $0.38 | $0.65 | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Options vested in period | 1,498,850 | 1,176,150 | 1,110,625 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Aggregate fair value of options vested in period | $700,000 | $700,000 | $800,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Unrecognized compensation cost related to stock options | 600,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Weighted average period for recognition of compensation cost | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | '2 years 6 months | ' | ' | ' | ' | '6 months 29 days | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Unrecognized compensation cost related to awards | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 0 | ' | ' | ' | ' | ' | ' | ' | ' |
Non-vested stock awards | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Granted | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 500,000 | ' | 305,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | 30,000 | 30,000 | 30,000 | ' | ' | ' | ' | ' |
Grant date fair value | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $0.45 | ' | $1.06 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Forfeitures | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 343,750 | ' | 141,400 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Vested | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 150,000 | ' | 155,100 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Vesting schedule for non-vested stock | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Vesting percentage, year one | ' | ' | ' | ' | ' | ' | ' | ' | ' | 50.00% | ' | ' | 0.00% | ' | 33.00% | ' | 33.00% | 33.00% | 33.00% | 0.00% | ' | ' | ' | ' | ' | ' | 25.00% | ' | ' | ' | ' |
Vesting percentage, year two | ' | ' | ' | ' | ' | ' | ' | ' | ' | 50.00% | ' | ' | 25.00% | ' | 33.00% | ' | 33.00% | 33.00% | 33.00% | 25.00% | ' | ' | ' | ' | ' | ' | 25.00% | ' | ' | ' | ' |
Vesting percentage, year three | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 25.00% | ' | 34.00% | ' | 34.00% | 34.00% | 34.00% | 25.00% | ' | ' | ' | ' | ' | ' | 25.00% | ' | ' | ' | ' |
Vesting percentage, year four | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 25.00% | ' | ' | ' | ' | ' | ' | 25.00% | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Vesting percentage, year five | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 25.00% | ' | ' | ' | ' | ' | ' | 25.00% | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
ESPP | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
ESPP, number of shares authorized | 2,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
ESPP, purchase date | '1 year 1 month | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
ESPP, purchase price as percentage of market value | 95.00% | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
ESPP, maximum subscription rate | 10.00% | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
ESPP, maximum subscription amount | 25,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Shares issued during period, Employee Stock Purchase Plan | ' | ' | ' | ' | 233,000 | ' | 273,000 | ' | 279,800 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Aggregate Grant-Date Fair Value, Employee Stock Purchase Plan | ' | ' | ' | ' | 30,000 | ' | 50,000 | ' | 50,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Other stock awards | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Term over which grants will occur | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | '10 years | ' | ' | ' | ' | ' | ' | ' |
Number of shares authorized under the Plan | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 5,000,000 | 1,500,000 | ' | 600,000 | ' | ' | ' | ' | ' | ' | ' |
Remaining shares available for grant under the Plan | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 2,936,850 | 1,375,250 | ' | 360,000 | ' | ' | ' | ' | ' | ' | ' |
Number of shares awarded annually to non-employee board members other than the non-executive chair | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 5,000 | ' | ' | ' | ' | ' | ' | ' |
Number of shares awarded annually to non-executive chair of the board of directors | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 10,000 | ' | ' | ' | ' | ' | ' | ' |
Aggregate grant-date fair value, non-employee director stock plan | ' | ' | ' | 20,000 | ' | 20,000 | ' | 20,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Share-based compensation expense | $900,000 | $700,000 | $600,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $200,000 | $800,000 | $700,000 | $600,000 |
Results_of_Discontinued_Operat
Results of Discontinued Operations (Details) (USD $) | 12 Months Ended | ||
Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | |
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | ' | ' | ' |
(Loss) income from discontinued operations, net of tax | ($4,450,000) | ($10,586,000) | $4,216,000 |
Gain (Loss) on Disposition of Business | 3,430,000 | 65,000 | 62,000 |
Portamedic Service Line [Member] | ' | ' | ' |
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | ' | ' | ' |
Revenue | 66,467,000 | 100,400,000 | 111,417,000 |
(Loss) income from discontinued operations, net of tax | -4,450,000 | -10,586,000 | 4,216,000 |
Gain (Loss) on Disposition of Business | 3,355,000 | 0 | 0 |
Discontinued Operation, Tax Effect of Discontinued Operation | $100,000 | $100,000 | $100,000 |
Details_of_Discontinued_Operat
Details of Discontinued Operation Assets (Details) (USD $) | Dec. 31, 2012 |
In Thousands, unless otherwise specified | |
Assets held for sale: | ' |
Inventories | $941 |
Other current assets | 400 |
Property, plant and equipment, net | 2,080 |
Other assets | 225 |
Total assets | 3,646 |
Liabilities held for sale: | ' |
Deferred rent | 104 |
Capital leases | 116 |
Total liabilities | $220 |
Discontinued_Operations_Narrat
Discontinued Operations (Narrative) (Details) (USD $) | 12 Months Ended | 0 Months Ended | 12 Months Ended | 3 Months Ended | ||||
Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | Sep. 30, 2013 | Dec. 31, 2013 | Sep. 30, 2013 | Sep. 30, 2013 | Mar. 31, 2014 | |
Portamedic Service Line [Member] | Portamedic Service Line [Member] | Other Current Assets [Member] | Other Long-Term Assets [Member] | Subsequent Event [Member] | ||||
Portamedic Service Line [Member] | Portamedic Service Line [Member] | Portamedic Service Line [Member] | ||||||
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' |
Amount of Holdback received | $6,053,000 | $0 | $0 | $8,100,000 | $6,100,000 | ' | ' | $800,000 |
Consideration amount | ' | ' | ' | 8,400,000 | ' | ' | ' | ' |
Holdback Amount | ' | ' | ' | 2,000,000 | ' | ' | ' | ' |
Holdback amount, component one | ' | ' | ' | 1,000,000 | ' | 1,000,000 | ' | ' |
Disposal Group, Including Discontinued Operation, Holdback Release, Business Days after Closing | ' | ' | ' | ' | '3 days | ' | ' | ' |
Holdback amount, component two | ' | ' | ' | 1,000,000 | ' | ' | 1,000,000 | ' |
Divestiture of Business Related Costs | ' | ' | ' | ' | 1,000,000 | ' | ' | ' |
Payments for Divestiture of Businesses | 781,000 | 0 | 0 | ' | ' | ' | ' | ' |
Lease obligation | 50,000 | ' | ' | ' | ' | ' | ' | ' |
Lease obligations, maximum exposure | 200,000 | ' | ' | ' | ' | ' | ' | ' |
Change in liabilities | $80,000 | $70,000 | $60,000 | ' | ' | ' | ' | ' |
Restructuring_Charges_Details
Restructuring Charges (Details) (USD $) | 12 Months Ended | ||
Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | |
Restructuring Reserve [Roll Forward] | ' | ' | ' |
Restructuring reserve, beginning balance | $700,000 | ' | ' |
Restructuring charges | 1,900,000 | 2,700,000 | 300,000 |
Payments | -1,700,000 | ' | ' |
Restructuring reserve, ending balance | 900,000 | 700,000 | ' |
Restructuring charges, continuing operations | 813,000 | 566,000 | 34,000 |
Restructuring charges, discontinued operations | 1,100,000 | 2,100,000 | 270,000 |
Restructuring reserve, current | 870,000 | 444,000 | ' |
Employee Severance [Member] | ' | ' | ' |
Restructuring Reserve [Roll Forward] | ' | ' | ' |
Restructuring reserve, beginning balance | 0 | ' | ' |
Restructuring charges | 1,300,000 | ' | ' |
Payments | -800,000 | ' | ' |
Restructuring reserve, ending balance | 500,000 | 0 | ' |
Restructuring charges, discontinued operations | ' | 900,000 | ' |
Facility Closing - Branch Office Closure [Member] | ' | ' | ' |
Restructuring Reserve [Roll Forward] | ' | ' | ' |
Restructuring reserve, beginning balance | 700,000 | ' | ' |
Restructuring charges | 600,000 | ' | ' |
Payments | -900,000 | ' | ' |
Restructuring reserve, ending balance | 400,000 | 700,000 | ' |
Restructuring charges, discontinued operations | ' | 1,200,000 | ' |
Accrued Liabilities [Member] | ' | ' | ' |
Restructuring Reserve [Roll Forward] | ' | ' | ' |
Restructuring reserve, current | 870,000 | ' | ' |
Other Long-Term Liabilities [Member] | ' | ' | ' |
Restructuring Reserve [Roll Forward] | ' | ' | ' |
Restructuring reserve, noncurrent | $80,000 | ' | ' |
Summary_of_Property_Plant_and_
Summary of Property, Plant and Equipment (Details) (USD $) | Dec. 31, 2013 | Dec. 31, 2012 |
In Thousands, unless otherwise specified | ||
Property, Plant and Equipment [Abstract] | ' | ' |
Land and improvements | $0 | $639 |
Buildings and leasehold improvements | 1,864 | 6,935 |
Furniture, fixtures and equipment | 9,542 | 9,650 |
Software | 4,612 | 3,605 |
Property, Plant and Equipment, Gross | 16,018 | 20,829 |
Accumulated depreciation and amortization | 12,257 | 15,195 |
Property, plant and equipment, net | $3,761 | $5,634 |
Property_Plant_and_Equipment_S
Property, Plant and Equipment Summary of Asset Lives (Details) | 12 Months Ended |
Dec. 31, 2013 | |
Building and leasehold improvements [Member] | Minimum [Member] | ' |
Property, Plant and Equipment, Useful Life | '3 years |
Building and leasehold improvements [Member] | Maximum [Member] | ' |
Property, Plant and Equipment, Useful Life | '45 years |
Furniture, fixtures and equipment [Member] | Minimum [Member] | ' |
Property, Plant and Equipment, Useful Life | '2 years |
Furniture, fixtures and equipment [Member] | Maximum [Member] | ' |
Property, Plant and Equipment, Useful Life | '10 years |
Software [Member] | Minimum [Member] | ' |
Property, Plant and Equipment, Useful Life | '1 year |
Software [Member] | Maximum [Member] | ' |
Property, Plant and Equipment, Useful Life | '7 years |
Property_Plant_and_Equipment_N
Property, Plant and Equipment Narrative (Details) (USD $) | Dec. 31, 2013 |
In Millions, unless otherwise specified | |
Property, Plant and Equipment [Abstract] | ' |
Assets held-for-sale | $0.70 |
Accrued_Expenses_Details
Accrued Expenses (Details) (USD $) | Dec. 31, 2013 | Dec. 31, 2012 |
In Thousands, unless otherwise specified | ||
Payables and Accruals [Abstract] | ' | ' |
Accrued wages | $332 | $1,292 |
Reserve for unclaimed property | 910 | 752 |
Restructuring reserve, current | 870 | 444 |
Other accrued expenses | 1,924 | 1,951 |
Accrued Expenses | $4,036 | $4,439 |
Loan_and_Security_Agreements_D
Loan and Security Agreements (Details) (USD $) | Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
2013 Loan and Security Agreement [Member] | 2013 Loan and Security Agreement [Member] | 2013 Loan and Security Agreement [Member] | 2013 Loan and Security Agreement [Member] | 2013 Loan and Security Agreement [Member] | 2013 Loan and Security Agreement [Member] | 2009 Loan and Security Agreement [Member] | 2009 Loan and Security Agreement [Member] | ||
Prime rate [Member] | LIBOR 90 day rate [Member] | Prior to second anniversary [Member] | Prior to third anniversary [Member] | First amendment [Member] | |||||
Loan and Security Agreements [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Loan and Security Agreement, Life of Agreement | ' | '3 years | ' | ' | ' | ' | ' | ' | ' |
Maximum borrowing capacity under Loan and Security Agreement | $10,000,000 | $10,000,000 | ' | ' | ' | ' | ' | ' | ' |
Loan maximum defined, based on eligible receivables | 85.00% | 85.00% | ' | ' | ' | ' | ' | ' | ' |
Reserve on eligible borrowings | 1,500,000 | 1,500,000 | ' | ' | ' | ' | ' | ' | ' |
Additional borrowing availability under Loan and Security Agreement | 2,000,000 | 2,000,000 | ' | ' | ' | ' | ' | ' | ' |
Borrowings outstanding under Loan and Security Agreement | 0 | 0 | ' | ' | ' | ' | ' | ' | ' |
Credit facility - early termination fee | ' | ' | ' | ' | 3.00% | 2.00% | ' | ' | ' |
Amendment fee | ' | ' | ' | ' | ' | ' | 200,000 | ' | ' |
Spread on variable rate | ' | ' | 2.75% | 5.25% | ' | ' | ' | ' | ' |
Interest rate, stated percentage | ' | 6.00% | ' | ' | ' | ' | ' | ' | ' |
Commitment fee | ' | 100,000 | ' | ' | ' | ' | ' | ' | ' |
Other issue costs | ' | 900,000 | ' | ' | ' | ' | ' | ' | ' |
Unused Capacity, Commitment Fee Percentage | ' | 1.00% | ' | ' | ' | ' | ' | ' | ' |
Unused line fee | ' | 100,000 | ' | ' | ' | ' | ' | 100,000 | 100,000 |
Annual Fee | ' | ' | ' | ' | ' | ' | ' | $100,000 | $100,000 |
Commitments_and_Contingencies_1
Commitments and Contingencies (Details) (USD $) | 12 Months Ended | ||
In Millions, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
operating_lease | |||
branch_office | |||
Commitments and Contingencies Disclosure [Abstract] | ' | ' | ' |
Number of offices | 16 | ' | ' |
Number of operating leases | 21 | ' | ' |
Employment agreements, contract term | '1 year | ' | ' |
Rental expense | $0.70 | $2 | $1.90 |
Rental expense, net of sublease rental income | 0.2 | ' | ' |
Branch closure obligation | $0.30 | ' | ' |
Commitments_and_Contingencies_2
Commitments and Contingencies Schedule of minimum lease payments (Details) (USD $) | Dec. 31, 2013 |
In Thousands, unless otherwise specified | |
Commitments and Contingencies Disclosure [Abstract] | ' |
Operating Leases, Future Minimum Payments, 2014 | $2,535 |
Operating Leases, Future Minimum Payments, 2015 | 1,806 |
Operating Leases, Future Minimum Payments, 2016 | 1,524 |
Operating Leases, Future Minimum Payments, 2017 | 1,378 |
Operating Leases, Future Minimum Payments, 2018 | 1,104 |
Operating Leases, Future Minimum Payments, Thereafter | 0 |
Operating Leases, Future Minimum Payments | $8,347 |
Litigation_Details
Litigation - (Details) (USD $) | 0 Months Ended |
In Millions, unless otherwise specified | Mar. 11, 2013 |
Commitments and Contingencies Disclosure [Abstract] | ' |
Settlement | $0.05 |
Income_Taxes_Income_taxes_Deta
Income Taxes Income taxes (Details) (USD $) | 12 Months Ended | ||
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
Income Tax Disclosure [Abstract] | ' | ' | ' |
Federal - current | $0 | $0 | $0 |
State and local - current | 19 | 23 | 36 |
Income tax expense | $19 | $23 | $36 |
Income_Taxes_Income_tax_rate_r
Income Taxes Income tax rate reconciliation (Details) | 12 Months Ended | ||
Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | |
Income Tax Disclosure [Abstract] | ' | ' | ' |
Computed expected income tax benefit | -35.00% | -35.00% | -35.00% |
Reduction (increase) in income tax benefit and increase (reduction) in income tax expense resulting from: | ' | ' | ' |
State tax, net of federal benefit | 0.00% | 0.00% | 0.00% |
Change in federal valuation allowance | 35.00% | 35.00% | 35.00% |
Other | 0.00% | 0.00% | 0.00% |
Effective income tax rate | 0.00% | 0.00% | 0.00% |
Income_Taxes_Net_deferred_tax_
Income Taxes Net deferred tax assets (Details) (USD $) | 12 Months Ended | |
Dec. 31, 2012 | Dec. 31, 2013 | |
Income Tax Disclosure [Abstract] | ' | ' |
Receivable allowance | $259,000 | $59,000 |
Goodwill | 6,459,000 | 4,238,000 |
Discontinued operations | 215,000 | 370,000 |
Fixed asset impairment | 675,000 | 0 |
Intangible assets | 1,309,000 | 845,000 |
Compensation expense | 1,399,000 | 1,518,000 |
Federal net operating loss carryforward | 40,773,000 | 48,990,000 |
State net operating loss carryforward | 5,109,000 | 5,756,000 |
AMT credit carry forward | 157,000 | 0 |
Accrued expenses | 65,000 | 25,000 |
Deferred rent | 177,000 | 131,000 |
Other | 182,000 | 167,000 |
Gross deferred tax assets | 56,779,000 | 62,099,000 |
Deferred Tax Assets, Valuation Allowance | -56,779,000 | -61,500,000 |
Deferred tax assets, net of valuation allowance | 0 | 599,000 |
Impairment and accumulated depreciation | 0 | -599,000 |
Gross deferred tax liabilities | 0 | -599,000 |
Net deferred tax assets | 0 | 0 |
Expired capital loss carryforwards | $2,000,000 | ' |
Income_Taxes_Net_Operating_Los
Income Taxes Net Operating Loss Carryforwards (Details) (USD $) | 12 Months Ended | 12 Months Ended | |||||
In Millions, unless otherwise specified | Dec. 31, 2012 | Dec. 31, 2013 | Sep. 30, 2013 | Dec. 31, 2013 | Dec. 31, 2011 | Dec. 31, 2011 | Dec. 31, 2011 |
Internal Revenue Service (IRS) [Member] | State and Local Jurisdiction [Member] | Current year [Member] | Current year [Member] | amended 2006-2008 [Member] | true-up 2010 [Member] | ||
NumberStates | NumberStates | NumberStates | NumberStates | ||||
Expired capital loss carryforwards | $2 | ' | ' | ' | ' | ' | ' |
State tax expense (ones) | ' | ' | ' | 1 | 2 | 1 | 2 |
Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration | ' | $140 | $127.20 | ' | ' | ' | ' |
401k_Savings_and_Retirement_Pl1
401(k) Savings and Retirement Plan (Details) | 12 Months Ended |
Dec. 31, 2013 | |
hours | |
Compensation and Retirement Disclosure [Abstract] | ' |
401(k) eligibility, minimum hours | 1,000 |
401(k) eligibility, minimum age | '21 years |
Segments_Details
Segments (Details) (USD $) | 3 Months Ended | 12 Months Ended | ||||||||||
In Thousands, unless otherwise specified | Dec. 31, 2013 | Sep. 30, 2013 | Jun. 30, 2013 | Mar. 31, 2013 | Dec. 31, 2012 | Sep. 30, 2012 | Jun. 30, 2012 | Mar. 31, 2012 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | Dec. 31, 2010 |
segment | ||||||||||||
Segment Reporting Information [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Revenues | $14,967 | $10,993 | $10,841 | $12,359 | $15,191 | $12,299 | $11,180 | $12,307 | $49,160 | $50,977 | $51,082 | ' |
Depreciation and amortization expense | ' | ' | ' | ' | ' | ' | ' | ' | 1,846 | 2,367 | 2,314 | ' |
Operating income (loss) | ' | ' | ' | ' | ' | ' | ' | ' | -9,756 | -7,037 | -7,771 | ' |
Capital expenditures | ' | ' | ' | ' | ' | ' | ' | ' | 525 | 2,087 | 1,955 | ' |
Segment assets | 21,646 | ' | ' | ' | 36,418 | ' | ' | ' | 21,646 | 36,418 | ' | ' |
Cash and cash equivalents | 3,970 | ' | ' | ' | 8,319 | ' | ' | ' | 3,970 | 8,319 | 16,917 | 21,391 |
Number of reportable segments | ' | ' | ' | ' | ' | ' | ' | ' | 3 | ' | ' | ' |
Intercompany eliminations [Member] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Segment Reporting Information [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Revenues | ' | ' | ' | ' | ' | ' | ' | ' | 1,100 | 2,100 | 2,000 | ' |
Health & Wellness [Member] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Segment Reporting Information [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Revenues | ' | ' | ' | ' | ' | ' | ' | ' | 23,149 | 21,349 | 18,441 | ' |
Depreciation and amortization expense | ' | ' | ' | ' | ' | ' | ' | ' | 655 | 563 | 409 | ' |
Operating income (loss) | ' | ' | ' | ' | ' | ' | ' | ' | 5 | 989 | 1,992 | ' |
Capital expenditures | ' | ' | ' | ' | ' | ' | ' | ' | 347 | 818 | 788 | ' |
Segment assets | 6,937 | ' | ' | ' | 6,261 | ' | ' | ' | 6,937 | 6,261 | ' | ' |
Heritage Labs [Member] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Segment Reporting Information [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Revenues | ' | ' | ' | ' | ' | ' | ' | ' | 11,390 | 13,154 | 13,664 | ' |
Depreciation and amortization expense | ' | ' | ' | ' | ' | ' | ' | ' | 423 | 620 | 455 | ' |
Operating income (loss) | ' | ' | ' | ' | ' | ' | ' | ' | 619 | 764 | 596 | ' |
Capital expenditures | ' | ' | ' | ' | ' | ' | ' | ' | 56 | 752 | 254 | ' |
Segment assets | 4,094 | ' | ' | ' | 4,624 | ' | ' | ' | 4,094 | 4,624 | ' | ' |
Hooper Holmes Services [Member] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Segment Reporting Information [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Revenues | ' | ' | ' | ' | ' | ' | ' | ' | 14,621 | 16,474 | 18,977 | ' |
Depreciation and amortization expense | ' | ' | ' | ' | ' | ' | ' | ' | 260 | 371 | 340 | ' |
Operating income (loss) | ' | ' | ' | ' | ' | ' | ' | ' | -1,716 | -2,475 | -3,348 | ' |
Capital expenditures | ' | ' | ' | ' | ' | ' | ' | ' | 0 | 109 | 413 | ' |
Segment assets | 1,994 | ' | ' | ' | 3,320 | ' | ' | ' | 1,994 | 3,320 | ' | ' |
Unallocated Corporate [Member] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Segment Reporting Information [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Revenues | ' | ' | ' | ' | ' | ' | ' | ' | 0 | 0 | 0 | ' |
Depreciation and amortization expense | ' | ' | ' | ' | ' | ' | ' | ' | 508 | 813 | 1,110 | ' |
Operating income (loss) | ' | ' | ' | ' | ' | ' | ' | ' | -8,664 | -6,315 | -7,011 | ' |
Capital expenditures | ' | ' | ' | ' | ' | ' | ' | ' | 122 | 408 | 500 | ' |
Segment assets | $8,621 | ' | ' | ' | $22,213 | ' | ' | ' | $8,621 | $22,213 | ' | ' |
Quarterly_Financial_Data_Unaud2
Quarterly Financial Data (Unaudited) (Details) (USD $) | 3 Months Ended | 12 Months Ended | |||||||||
In Thousands, except Per Share data, unless otherwise specified | Dec. 31, 2013 | Sep. 30, 2013 | Jun. 30, 2013 | Mar. 31, 2013 | Dec. 31, 2012 | Sep. 30, 2012 | Jun. 30, 2012 | Mar. 31, 2012 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
Quarterly Financial Data [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Revenues from external customers | $14,967 | $10,993 | $10,841 | $12,359 | $15,191 | $12,299 | $11,180 | $12,307 | $49,160 | $50,977 | $51,082 |
Gross profit | 3,818 | 1,973 | 2,552 | 3,199 | 3,947 | 3,282 | 2,754 | 3,316 | 11,542 | 13,299 | 13,556 |
(Loss) income from continuing operations | -1,487 | -3,564 | -3,177 | -2,027 | -1,059 | -1,318 | -2,614 | -2,086 | -10,255 | -7,077 | -7,802 |
Income from discontinued operations | -512 | 1,850 | -1,825 | -533 | -5,678 | -875 | -2,916 | -1,052 | ' | ' | ' |
Net loss | ($1,999) | ($1,714) | ($5,002) | ($2,560) | ($6,737) | ($2,193) | ($5,530) | ($3,138) | ($11,275) | ($17,598) | ($3,524) |
Continuing operations, basic (usd per share) | ($0.02) | ($0.05) | ($0.05) | ($0.03) | ($0.02) | ($0.02) | ($0.04) | ($0.03) | ($0.15) | ($0.10) | ($0.11) |
Discontinued operations, basic (usd per share) | ($0.01) | $0.03 | ($0.03) | ($0.01) | ($0.08) | ($0.01) | ($0.04) | ($0.02) | ($0.01) | ($0.15) | $0.06 |
Net (loss) income, basic (usd per share) | ($0.03) | ($0.02) | ($0.07) | ($0.04) | ($0.10) | ($0.03) | ($0.08) | ($0.05) | ($0.16) | ($0.25) | ($0.05) |
Continuing operations, diluted (usd per share) | ($0.02) | ($0.05) | ($0.05) | ($0.03) | ($0.02) | ($0.02) | ($0.04) | ($0.03) | ($0.15) | ($0.10) | ($0.11) |
Discontinued operations, diluted (usd per share) | ($0.01) | $0.03 | ($0.03) | ($0.01) | ($0.08) | ($0.01) | ($0.04) | ($0.02) | ($0.01) | ($0.15) | $0.06 |
Net (loss) income, diluted (usd per share) | ($0.03) | ($0.02) | ($0.07) | ($0.04) | ($0.10) | ($0.03) | ($0.08) | ($0.05) | ($0.16) | ($0.25) | ($0.05) |
Quarterly_Financial_Data_Unaud3
Quarterly Financial Data (Unaudited) - Additional Information (Details) (USD $) | 3 Months Ended | 12 Months Ended | 3 Months Ended | 9 Months Ended | |||||||||||
In Thousands, unless otherwise specified | Dec. 31, 2013 | Sep. 30, 2013 | Jun. 30, 2013 | Mar. 31, 2013 | Dec. 31, 2012 | Sep. 30, 2012 | Jun. 30, 2012 | Mar. 31, 2012 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2012 |
Restatement Adjustment [Member] | Restatement Adjustment [Member] | Restatement Adjustment [Member] | Restatement Adjustment [Member] | ||||||||||||
Cost of operations | ' | ' | ' | ' | ' | ' | ' | ' | $37,618 | $37,678 | $37,526 | $300 | $300 | $800 | $900 |
Gross profit | 3,818 | 1,973 | 2,552 | 3,199 | 3,947 | 3,282 | 2,754 | 3,316 | 11,542 | 13,299 | 13,556 | -300 | -300 | -800 | -900 |
Selling, general and administrative expenses | ' | ' | ' | ' | ' | ' | ' | ' | 20,273 | 19,543 | 21,293 | 30 | -70 | -30 | -200 |
Other (expense) income, net | ' | ' | ' | ' | ' | ' | ' | ' | -399 | -33 | -39 | 50 | 60 | 200 | 200 |
(Loss) income from continuing operations | -1,487 | -3,564 | -3,177 | -2,027 | -1,059 | -1,318 | -2,614 | -2,086 | -10,255 | -7,077 | -7,802 | 300 | 100 | 600 | 600 |
Income from discontinued operations | ($512) | $1,850 | ($1,825) | ($533) | ($5,678) | ($875) | ($2,916) | ($1,052) | ' | ' | ' | $300 | $100 | $600 | $600 |
Schedule_II_Valuation_and_Qual1
Schedule II - Valuation and Qualifying Accounts (Details) (USD $) | 12 Months Ended | ||
Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | |
Movement in Valuation Allowances and Reserves [Roll Forward] | ' | ' | ' |
Balance, beginning of period | $662,000 | $525,000 | $910,000 |
Charged to Revenues and Expenses | 1,576,000 | 2,359,000 | 2,030,000 |
Deductions | -2,085,000 | -2,222,000 | -2,415,000 |
Balance, end of period | 153,000 | 662,000 | 525,000 |
Reduction to revenues | $1,600,000 | $2,200,000 | $190,000 |